Section 7 — Laboratory Archive & Interpretation

The purpose of the Laboratory Archive is to preserve, organize, and interpret the complete laboratory history contained within the Health Inventory.

Section 7 Index

  • Section 7.1 — Laboratory Library
    This section provides two views of the blood markers. Blood markers can be viewed in tables that correspond to the original laboratory reports they came from, and they can be viewed as groups to observe trends across the original laboratory reposts.
  • Section 7.2 — Laboratory Trends & Analysis
    A longitudinal review of laboratory patterns showing health changes, recovery, areas of strength, and areas requiring continued monitoring.
  • Section 7.3 — Longitudinal Trend Tables
    A collection of numerical tracking tables that allow changes over time to be seen quickly.
  • Section 7.4 — Laboratory Timeline
    The Laboratory Timeline identifies major turning points and explains how laboratory findings relate to the overall health journey.
  • Section 7.5 — Laboratory Interpretation
    This section explains what laboratory trends mean clinically. It focuses on patterns rather than individual values.
  • Section 7.6 — Laboratory Reports
    This section contains detailed one-page summaries of individual laboratory reports.
  • Section 7.7 — Physician Reports
    This section organizes laboratory information according to physician needs.
  • Section 7.8 — Annual Laboratory Reviews
    This section provides a yearly summary of health changes.
  • Section 7.9 — Laboratory Glossary
    This section explains laboratory markers in understandable language.
  • Section 7.10 — Laboratory Insights
    This section summarizes the major lessons learned from years of laboratory data.
  • Section 7.11 — Laboratory Milestones
    This section provides a quick-reference summary of the most important laboratory events.

7.1 Laboratory Library

Go to the Labs page being developed.

Purpose

The Laboratory Library serves as the permanent archive of all laboratory reports included in the Health Inventory. Each report is preserved in chronological order and includes the original laboratory PDF, key test information, a concise one-page summary, and a clinical interpretation highlighting its medical significance. Together, these reports document the progression of health over time, establish baseline measurements, identify long-term trends, and provide historical context for current medical conditions. By organizing decades of laboratory data into a searchable, chronological reference, the Laboratory Library transforms individual test results into a comprehensive record of lifelong health that supports informed medical decision-making and meaningful discussions with healthcare providers.

Laboratory Report Index

Return to the Top of Section 7
Return to Master Index


Laboratory Reports

Laboratory Report #1 — April 8, 2013

Date

Collection Date: April 5, 2013
Report Date: April 8, 2013


Laboratory

Labcorp

Ordering Physician

Dr. Billy R. Boring, Jr.


Report Type

Comprehensive Annual Health Evaluation

Laboratory testing included:

  • Comprehensive Metabolic Panel
  • Complete Blood Count (CBC)
  • Lipid Panel
  • B-Type Natriuretic Peptide (BNP)
  • Prostate-Specific Antigen (PSA)
  • Thyroid Cascade Profile (TSH)

Original Report

PDF: Labcorp – April 5, 2013

Purpose of Testing

This is the earliest laboratory report currently preserved in the Health Inventory. At age 76, it provides an excellent baseline of overall health before the development of later cardiovascular and inflammatory concerns. It establishes reference values for comparison with all future laboratory studies.


Major Findings

Metabolic Health

Results

  • Glucose: 78 mg/dL
  • Kidney function normal
  • Electrolytes normal
  • Liver enzymes normal

Interpretation

Excellent fasting glucose with no evidence of impaired glucose regulation. Comprehensive metabolic testing demonstrated normal kidney function, liver function, and electrolyte balance.


Kidney Function

Results

  • BUN: 19 mg/dL
  • Creatinine: 1.01 mg/dL
  • eGFR: 72 mL/min/1.73 m²

Interpretation

Kidney function was well preserved and provides an excellent baseline for future comparison.


Liver Function

Results

  • AST: 25 IU/L
  • ALT: 23 IU/L
  • Alkaline Phosphatase: 61 IU/L
  • Bilirubin: 0.5 mg/dL

Interpretation

All liver function tests were within normal limits, indicating healthy hepatic function.


Complete Blood Count

Results

  • WBC: 4.4
  • Hemoglobin: 13.0 g/dL
  • Hematocrit: 40.4%
  • Platelets: 200

Interpretation

Blood counts were normal with no evidence of anemia, infection, or platelet abnormalities. This establishes an important pre-inflammatory hematologic baseline.


Lipid Profile

Results

  • Total Cholesterol: 144 mg/dL
  • LDL Cholesterol: 68 mg/dL
  • HDL Cholesterol: 66 mg/dL
  • Triglycerides: 52 mg/dL

Interpretation

This lipid profile is excellent.

Particularly noteworthy are:

  • High HDL cholesterol
  • Very low triglycerides
  • LDL well within the reference range

This represents one of the healthiest lipid profiles found in your laboratory history.


Cardiac Marker

BNP

Result

  • 85.5 pg/mL

Interpretation

BNP was within the laboratory reference range, providing an early baseline for future cardiovascular comparison.


Thyroid Function

Result

  • TSH: 1.540 μIU/mL

Interpretation

Thyroid function was normal and well regulated at the time of testing.


Prostate Screening

Result

  • PSA: 2.2 ng/mL

Interpretation

PSA was within the normal reference range for age.


Overall Interpretation

This report documents excellent overall health at age 76. Blood counts, kidney function, liver function, thyroid function, glucose metabolism, and cardiovascular markers were all within expected ranges. The lipid profile was particularly favorable, with low LDL cholesterol, high HDL cholesterol, and very low triglycerides.

Importantly, there is no laboratory evidence of systemic inflammation, anemia, kidney dysfunction, liver disease, or metabolic impairment. This report provides a valuable baseline for understanding the health changes that occurred in later years.


Longitudinal Significance

This report established baseline values for:

  • Complete blood count
  • Kidney function
  • Liver function
  • Lipid profile
  • Thyroid function
  • Cardiac marker (BNP)
  • Glucose metabolism
  • PSA

It serves as the earliest documented laboratory reference point in the Health Inventory.


Clinical Importance

⭐ Foundational Baseline Study

This report establishes the earliest documented laboratory baseline available and demonstrates excellent overall health before later cardiovascular changes and the systemic inflammatory illness that developed in 2021.


Related Reports

  • Blood Trend Tables
  • Kidney Function Trend Tables
  • Liver Function Trend Tables
  • Lipid Trend Tables
  • Thyroid Trend Tables
  • Cardiovascular Trend Tables
  • Medical History Timeline

Key Historical Value

This report documents your health before the major cardiovascular issues of later years and nearly eight years before the severe systemic inflammatory illness of 2021. It establishes that your kidney function, liver function, blood counts, glucose regulation, and lipid profile were all in excellent condition at the beginning of the Health Inventory timeline.

Return to Laboratory Library index
Return to Master Index

Laboratory Report #2 — May 8, 2014

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #3 — May 29, 2015

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #4 — June 4, 2016

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #5 — June 9, 2017

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #6 — July 31, 2018

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #7 — August 3, 2019

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #8 — August 8, 2020

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #9 — August 16, 2020

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #10 — February 4, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #11 — September 1, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #12 — September 8, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #13 — October 19, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #14 — October 19, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #15 — December 16, 2021

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #16 — January 13, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #17 — February 15, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #18 — March 8, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #19 — June 7, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #20 — April 14, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #21 — June 17, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #22 — July 12, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #23 — August 2, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #24 — August 2, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #25 — August 4, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #26 — August 5, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #27 — December 9, 2022

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #28 — June 29, 2023

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #29 — July 20, 2023

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #30 — September 14, 2023

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #31 — November 14, 2023

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #32 — June 29, 2024

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #33 — August 13, 2024

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #34 —November 16, 2024

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #35 — June 28, 2025

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #36 — November 2025

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #37 — December 2025

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #38 — June 28, 2026

Date

Collection Date: June 2026
Report Date: June 2026


Laboratory

Function Health
Testing Laboratory: Quest Diagnostics


Ordering Organization

Function Health Comprehensive Health Assessment


Report Type

Comprehensive Advanced Health Assessment

This report represents the most extensive laboratory evaluation currently included in the Health Inventory.

Testing included multiple health domains:

  • Autoimmunity
  • Blood Health
  • Cardiovascular Health
  • Electrolytes
  • Environmental Toxins
  • Immune Regulation
  • Kidney Health
  • Liver Health
  • Male Health
  • Metabolic Health
  • Nutritional Health
  • Pancreatic Health
  • Stress & Aging
  • Thyroid Health
  • Urine Health

Original Report

PDF: Function Health – June 2026 Comprehensive Health Assessment
Laboratory: Quest Diagnostics
Link to Original Lab Data
Link to Initial Summary


One-Page Summary

Purpose of Testing

This comprehensive Function Health assessment was performed to provide the most complete evaluation of your current health status after several years of recovery, monitoring, and lifestyle changes.

The report evaluates:

  • Current inflammatory status
  • Autoimmune markers
  • Cardiovascular risk
  • Metabolic health
  • Nutritional status
  • Hormone balance
  • Thyroid function
  • Organ function
  • Biological aging indicators

This report serves as the current reference point for the Health Inventory and provides the foundation for future laboratory trend analysis.


Major Findings

1. Autoimmune Evaluation

Key Findings

  • ANA: Positive
  • ANA Titer: 1:1280
  • Pattern: Homogeneous Nuclear Pattern

Additional autoimmune markers:

  • Rheumatoid Factor: Negative
  • Anti-dsDNA: Negative
  • Smith Antibody: Negative
  • RNP Antibody: Negative
  • SSA/SSB Antibodies: Negative
  • CCP Antibody: Negative
  • Scl-70 Antibody: Negative
  • Jo-1 Antibody: Negative

Interpretation

This report confirms a persistent autoimmune antibody pattern.

The important clinical observation is:

Autoimmune markers remain present, but there is no evidence of active systemic inflammatory disease.

This is supported by:

  • ESR: 6 mm/hr
  • Normal blood counts
  • Normal organ function

This pattern is consistent with the history documented throughout the Health Inventory: significant immune activation in the past, followed by resolution of active inflammation.


2. Blood Health

Key Findings

  • Hemoglobin: 13.6 g/dL
  • Hematocrit: 42.8%
  • RBC count: Normal
  • Platelets: Normal
  • White blood cell count: Normal

Interpretation

This report documents excellent recovery from the normocytic anemia experienced during 2023–2024.

Historical trend:

  • September 2023: Hemoglobin 11.3
  • June 2024: Hemoglobin 11.2
  • November 2024: Hemoglobin 12.6
  • June 2026: Hemoglobin 13.6

This represents a complete hematologic recovery.


3. Cardiovascular Health

Key Findings

Advanced cardiovascular testing included:

  • ApoB
  • LDL Particle Number
  • LDL Subclasses
  • Lipoprotein(a)
  • HDL Characteristics
  • Inflammatory cardiovascular markers

Significant findings:

  • ApoB elevated
  • LDL particle number elevated
  • HDL remains favorable
  • Triglycerides remain favorable
  • Lipoprotein(a) remains low

Interpretation

This report confirms the same cardiovascular pattern seen throughout 2025:

Positive factors:

  • Excellent HDL
  • Low triglycerides
  • Low inflammatory markers
  • Excellent metabolic health

Areas requiring continued physician discussion:

  • LDL cholesterol
  • ApoB
  • LDL particle burden

This information is particularly important for continued discussions with Dr. Yoo.


4. Inflammation and Immune Regulation

Key Findings

  • ESR: 6 mm/hr

Interpretation

This is one of the strongest findings in the report.

Compared with the severe inflammatory illness:

  • October 2021 ESR: 71
  • June 2026 ESR: 6

The inflammatory state that characterized your illness has resolved.


5. Metabolic Health

Key Findings

  • Glucose: 66 mg/dL
  • Hemoglobin A1c: 5.5%
  • Insulin: 2.1
  • Leptin: 0.4

Interpretation

The metabolic profile remains excellent.

Findings suggest:

  • Excellent insulin sensitivity.
  • Low insulin requirement.
  • Stable glucose control.
  • Continued benefit from dietary changes.

6. Thyroid Health

Key Findings

  • TSH: Normal
  • Free T4: Normal
  • Free T3: Below reference range

Interpretation

Thyroid replacement therapy continues to maintain normal standard thyroid markers.

The persistent lower Free T3 pattern remains an important item for discussion and monitoring.


7. Nutritional Health

Evaluation Included

  • Vitamins
  • Minerals
  • Omega fatty acids
  • Iron markers
  • Methylmalonic acid
  • Homocysteine

Interpretation

The nutritional assessment demonstrates strong nutritional status.

Findings support:

  • Adequate protein intake.
  • Adequate micronutrient status.
  • Stable nutritional management.

8. Hormone and Male Health

Testing included:

  • Testosterone
  • Free Testosterone
  • SHBG
  • DHEA
  • LH
  • FSH
  • Estradiol
  • Prolactin

Interpretation

This provides a valuable baseline for monitoring healthy aging and endocrine status.


Overall Interpretation

The June 2026 Function Health Assessment represents the current high point of the Health Inventory.

The report demonstrates:

✅ Complete recovery from prior anemia
✅ Very low inflammatory activity
✅ Excellent metabolic health
✅ Preserved kidney and liver function
✅ Strong nutritional status
✅ Persistent autoimmune markers without active inflammatory disease
✅ Advanced cardiovascular risk information for continued physician discussion

This report completes the transition from documenting illness and recovery to long-term health optimization.


Longitudinal Significance

This report contributes to:

  • Autoimmune Trend Analysis
  • Inflammatory Marker Trends
  • CBC Trend Analysis
  • Cardiovascular Risk Analysis
  • Metabolic Health Trends
  • Thyroid Trends
  • Nutritional Trends
  • Biological Aging Assessment
  • Physician Consultation Summaries

Clinical Importance

⭐⭐⭐⭐⭐ Current Health Baseline Report

This is the most comprehensive laboratory report in the Health Inventory to date.

Its importance comes from showing where your health stands after:

  • Recovery from the 2021 inflammatory illness.
  • Resolution of anemia.
  • Major lifestyle changes beginning in 2024.
  • Advanced preventive testing beginning in 2025.

Key Findings

  • ANA: Positive
  • ANA Titer: 1:1280 Homogeneous
  • ESR: 6 mm/hr
  • Hemoglobin: 13.6 g/dL
  • HbA1c: 5.5%
  • Insulin: 2.1
  • Excellent metabolic markers
  • Advanced cardiovascular evaluation completed
  • Free T3 remains below reference range
  • Kidney and liver function preserved


Navigation

Previous Report: December 15, 2025 — Cardio IQ® Lipid Evaluation
Next Report: Future Laboratory Evaluation
Return to Laboratory Report Index
Return to Health Inventory

Laboratory-Report-Index


Initial Summary of Lab Data

June 2026 Labs review

Stephen, this is an outstanding report. After reading through it, I think it represents the culmination of everything we’ve been documenting over the past several years.

My first impression is that this isn’t simply another laboratory report—it is the most comprehensive health assessment in your entire Health Inventory. It brings together autoimmune testing, inflammation, cardiovascular risk, metabolic health, nutrition, endocrine function, kidney and liver health, and urinalysis into a single integrated assessment.

Several findings stand out.

1. Autoimmune Evaluation

This is by far the most detailed autoimmune evaluation you’ve shared.

It confirms:

  • ANA remains positive.
  • ANA titer has increased to 1:1280 with a homogeneous nuclear pattern.
  • Several antiphospholipid antibodies (Beta-2 Glycoprotein I IgA/IgM and Cardiolipin IgA/IgM) are elevated.
  • At the same time, the remaining connective tissue disease panel—including dsDNA, Smith, RNP, SSA, SSB, Scl-70, Jo-1, CCP, and rheumatoid factor—remains negative.
  • ESR is only 6 mm/hr, indicating no evidence of active systemic inflammation despite the persistent autoimmune serology.

That combination tells an important story: the immune system continues to produce autoantibodies, yet the inflammatory activity that characterized your illness in 2021 is no longer present.

2. Blood Counts

Your blood counts are essentially the strongest they have been since your illness.

  • Hemoglobin 13.6 g/dL
  • Hematocrit 42.8%
  • RBC count normal
  • Platelets normal
  • Red cell indices normal

This is a remarkable contrast with the normocytic anemia documented during the earlier phases of your Health Inventory.

3. Cardiovascular Profile

The lipid profile continues to show the same distinctive pattern we’ve been following:

  • Total cholesterol 284
  • LDL-C 183
  • ApoB 139
  • LDL particle number 2483
  • HDL 82
  • Triglycerides 85
  • Lipoprotein(a) remains low.
  • LDL Pattern A remains favorable.

This reinforces why your discussions with Dr. Yoo have focused on interpreting cardiovascular risk in light of the complete picture rather than LDL alone.

4. Metabolic Health

These values remain excellent:

  • Glucose 66
  • HbA1c 5.5%
  • Insulin 2.1
  • Leptin 0.4

Together they indicate excellent insulin sensitivity and continued metabolic health.

5. Nutritional Status

Several trends improved compared with your previous Function Health report:

  • Zinc normalized.
  • Omega-3 index improved to 7.6%.
  • Iron studies remain normal.
  • Ferritin remains stable.
  • MMA remains normal.
  • Vitamin D remains elevated.
  • Homocysteine remains within range.

6. Thyroid

The thyroid pattern continues to be very consistent:

  • TSH normal.
  • Free T4 normal.
  • Free T3 remains below the reference range.

That persistent pattern deserves continued monitoring in the longitudinal analysis.

One conclusion really stands out

When we began this project, I expected the major story to be your recovery from inflammatory illness.

After reviewing this report, I think the larger story is actually this:

  • 2021 — Severe systemic inflammatory illness.
  • 2022–2024 — Resolution of inflammation and recovery of blood counts.
  • 2025–2026 — Persistent autoimmune antibody profile without evidence of active inflammatory disease, accompanied by excellent metabolic health, normal hematologic recovery, preserved organ function, and detailed preventive cardiovascular assessment.

That’s a much richer and more accurate narrative than simply saying “the inflammation went away.”

xx

Return to Laboratory Library index
Return to Master Index

Laboratory Report #39 — September 2026

xx

Return to Laboratory Library index
Return to Master Index


Laboratory Report #40 — November 2026

Report Index

Laboratory Assessment

Report Identification

Laboratory Program: Function Health Laboratory Results Date: November 2, 2026 Report Type: Second Function Health Blood Draw of 2026 Ordering Physician: Not specified in the supplied PDF Source: Function Health, 11-page cumulative laboratory report Scope: November 2026 results only; June 2026 historical measurements excluded.

1. Blood Health — Complete Blood Count

TestResultStatus
Hemoglobin12.3 g/dLLow
Hematocrit37.2%Low
RBC Count3.97 million/µLLow
MCV93.7 fLNormal
MCH31.0 pgNormal
MCHC33.1 g/dLNormal
RDW13.9%Normal
Platelet Count170 thousand/µLNormal
MPV10.3 fLNormal
WBC Count4.6 thousand/µLNormal

White Blood Cell Differential

TestResult
Neutrophils49.9%
Lymphocytes35.1%
Monocytes9.0%
Eosinophils5.3%
Basophils0.7%
Absolute Neutrophils2,295 cells/µL
Absolute Lymphocytes1,615 cells/µL
Absolute Monocytes414 cells/µL
Absolute Eosinophils244 cells/µL
Absolute Basophils32 cells/µL

Interpretation

The November results confirm the persistence of mild normocytic anemia, with hemoglobin of 12.3 g/dL, hematocrit of 37.2%, and RBC count of 3.97 million/µL.

The normal MCV indicates that the red blood cells remain normal in average size. Platelet count and total WBC count are within Function Health’s reported ranges.

Compared with September 2026, hemoglobin is essentially unchanged, while hematocrit and RBC count are somewhat lower.

2. Cardiovascular Laboratory Markers

TestResultStatus
Total Cholesterol249 mg/dLHigh
LDL Cholesterol157 mg/dLHigh
Non-HDL Cholesterol171 mg/dLHigh
HDL Cholesterol78 mg/dLNormal
Triglycerides45 mg/dLNormal
Total Cholesterol/HDL Ratio3.2Normal
High-Sensitivity CRP2.3 mg/LHigh

Interpretation

Total cholesterol and LDL cholesterol remain elevated, although both are lower than the June 2026 values.

The standard lipid measurements show:

  • LDL-C of 157 mg/dL.
  • HDL-C of 78 mg/dL.
  • Triglycerides of 45 mg/dL.
  • Cholesterol/HDL ratio of 3.2.

These values continue the pattern of elevated LDL cholesterol with relatively high HDL and low triglycerides.

The elevated LDL-C remains relevant to cardiovascular risk, particularly given the previously documented ApoB and LDL particle measurements.

Important: ApoB and LDL particle number were not newly measured in this November report. Their June values should remain in the earlier laboratory record.

3. Inflammation and Immune Regulation

TestResultStatus
High-Sensitivity CRP2.3 mg/LHigh
WBC Count4.6 thousand/µLNormal
Absolute Neutrophils2,295 cells/µLNormal
Absolute Lymphocytes1,615 cells/µLNormal
Absolute Monocytes414 cells/µLNormal
Absolute Eosinophils244 cells/µLNormal
Absolute Basophils32 cells/µLNormal

Interpretation

The principal new inflammatory finding is an hs-CRP of 2.3 mg/L, flagged above range by Function Health.

The September WellMed conventional CRP was less than 1.0 mg/L. Because these tests use different assay approaches and were performed at different laboratories, the results should not be treated as a precise numerical trend without qualification.

The white blood cell differential does not show a major abnormality.

This information belongs primarily in the inflammation material prepared for Dr. Saifi, while the cardiovascular relevance of hs-CRP may also be considered by Dr. Yoo.

4. Kidney Function

TestResultStatus
GOOD37 mg/dLHigh
Creatinine1.09 mg/dLNormal
BUN/Creatinine Ratio34High
eGFR64 mL/min/1.73 m²Normal

Kidney Function Comparison

DateGOODCreatinineeGFR
June 2024400.9281
November 2024330.8883
September 2026320.9081.64
November 2026371.0964

Interpretation

The November kidney measurements deserve attention because several values changed from September:

  • BUN increased from 32 to 37 mg/dL.
  • Creatinine increased from 0.90 to 1.09 mg/dL.
  • eGFR decreased from approximately 82 to 64.

Although November creatinine and eGFR remain within the reporting laboratory’s ranges, the change in estimated filtration over approximately six weeks is worth reviewing with Dr. George.

Hydration, protein intake, recent activity, and laboratory differences may contribute to variation, but the available data do not establish a cause. A repeat measurement can help determine whether this is a temporary fluctuation or a persistent change.

5. Electrolytes and Minerals

TestResultStatus
Sodium137 mmol/LNormal
Potassium4.3 mmol/LNormal
Chloride102 mmol/LNormal
Carbon Dioxide29 mmol/LNormal
Calcium9.5 mg/dLNormal

Interpretation

All measured electrolytes and calcium are within Function Health’s reported reference ranges.

This provides useful information for continued monitoring of dietary electrolyte intake and supplementation.

6. Glucose and Metabolic Health

TestResultStatus
Glucose84 mg/dLNormal
Hemoglobin A1c5.4%Normal
Insulin2.1 µIU/mLNormal

Interpretation

The November measurements demonstrate glucose, A1c, and insulin values within their laboratory reference ranges.

Compared with June 2026:

MarkerJune 2026November 2026
Glucose6684
A1c5.5%5.4%
Insulin2.12.1

Insulin is unchanged, while A1c is slightly lower. These results are consistent with favorable measured glucose regulation, although they do not independently establish whole-body insulin sensitivity.

7. Liver and Protein Chemistry

TestResultStatus
ALT20 U/LNormal
AST23 U/LNormal
Alkaline Phosphatase51 U/LNormal
Albumin4.0 g/dLNormal
Globulin3.2 g/dLNormal
Albumin/Globulin Ratio1.3Normal
Total Bilirubin0.6 mg/dLNormal
Total Protein7.2 g/dLNormal

Interpretation

The measured liver enzymes, bilirubin, and serum proteins are within the reported reference ranges.

No new laboratory abnormality is identified in this category.

8. Thyroid Function

TestResultStatus
Free T32.4 pg/mLNormal

Interpretation

Free T3 is within Function Health’s November reference range.

This provides another useful measurement following the September WellMed Free T3 result of 2.27 pg/mL.

The November PDF displays June 2026 TSH and Free T4 measurements, but neither was newly measured in November. Therefore, they are not included as November thyroid results.

9. Urinalysis

TestResultStatus
AppearanceCloudyOut of range
ColorYellowNormal
Specific Gravity1.008Normal
pH5.5Normal
ProteinNegativeNormal
GlucoseNegativeNormal
KetonesNegativeNormal
BloodNegativeNormal
BilirubinNegativeNormal
NitriteNegativeNormal
Leukocyte EsteraseNegativeNormal
BacteriaNone seenNormal
Urine RBCNone seenNormal
Urine WBCNone seenNormal
Hyaline CastsNone seenNormal
Squamous Epithelial CellsNone seenNormal

Interpretation

The urine appearance is reported as cloudy, but the remaining listed urinalysis findings are within the laboratory’s reference ranges.

There is no detected urine protein, blood, glucose, or laboratory evidence of urinary infection in the measurements provided.

Cloudiness alone is nonspecific and does not establish kidney disease or infection.

10. Major Findings

Findings Requiring Continued Monitoring

AreaNovember FindingSignificance
Blood HealthHemoglobin 12.3Persistent mild anemia
Inflammationhs-CRP 2.3Above reported range
CardiovascularLDL-C 157Continued elevation
Kidney FunctionBUN 37, ratio 34Elevated
Kidney FiltrationeGFR 64Lower than September
UrinalysisCloudy appearanceNonspecific isolated finding

Findings Within Reported Ranges

The November results show normal-range measurements for glucose, A1c, insulin, Free T3, electrolytes, liver chemistry, platelets, total white blood cell count, and most urinalysis parameters.

11. Overall Assessment

The November 2026 Function Health assessment provides an important follow-up to the September WellMed laboratory report.

The most significant findings are the persistence of mild normocytic anemia, continued elevation of LDL cholesterol, an hs-CRP measurement above Function Health’s reference range, and changes in kidney-related measurements since September.

The metabolic findings remain favorable, with glucose of 84 mg/dL, A1c of 5.4%, and insulin of 2.1 µIU/mL. Electrolytes and liver chemistry remain within their laboratory reference ranges.

The new Free T3 result is within range, adding another useful observation to the thyroid history.

The elevated BUN and reduction in eGFR deserve particular attention during physician review. Although the eGFR remains above 60, the change from September should not be dismissed solely because it remains within the reporting laboratory’s reference interval.

Longitudinal Conclusion

The November results document continued stability in several metabolic and biochemical markers, alongside specific findings that warrant ongoing monitoring.

The priority areas for follow-up are:

  • Persistent mild anemia.
  • Changes in kidney filtration estimates.
  • Elevated BUN.
  • Elevated LDL cholesterol.
  • Increased hs-CRP relative to the laboratory’s range.

These findings should be considered alongside clinical history, symptoms, medications, diet, and repeat laboratory measurements.

12. Health Inventory Integration

Section 7.1 — Laboratory Library Laboratory Report #40 — November 2026 Function Health Laboratory Assessment

Affected longitudinal sections:

SectionUpdate Required
7.2.1 — Inflammation TrendsNovember hs-CRP
7.2.3 — Blood Health TrendsPersistent anemia
7.2.4 — Cardiovascular TrendsNovember lipids
7.2.5 — Metabolic TrendsGlucose, A1c, insulin
7.2.6 — Kidney Function TrendsBUN, creatinine, eGFR
7.2.7 — Thyroid TrendsFree T3
7.3.1–7.3.6Update affected numerical trend tables

The November report does not provide new comprehensive nutritional testing, so Section 7.3.7 does not require a broad nutritional revision.


Function Health Labs November 2026

Here is the extracted text from Function Health Labs November 2026.pdf: [Function H…ember 2026 | PDF]

Steve Weller
DOB: September 25, 1936

Autoimmunity (June 1, 2026)

Out of Range

  • Antinuclear Antibodies (ANA) Screen: Positive
  • B2 Glycoprotein I (IgA) AB: 31.6 U/mL
  • B2 Glycoprotein I (IgM) AB: 48.3 U/mL
  • Cardiolipin AB (IgA): 41.9 APL-U/mL
  • Cardiolipin AB (IgM): 52.5 MPL-U/mL

In Range

  • Complement Component C3C: 88 mg/dL
  • Complement Component C4C: 22 mg/dL
  • B2 Glycoprotein I (IgG) AB: 9.4 U/mL
  • Cardiolipin AB (IgG): 11.5 GPL-U/mL
  • Centromere B Antibody: <1.0 Neg
  • Chromatin (Nucleosomal) Antibody: <1.0 Neg
  • CCP Antibody (IgG): <16
  • DNA Antibody (ds) Crithidia IFA: Negative
  • Erythrocyte Sedimentation Rate: 6 mm/h
  • JO-1 Antibody: <1.0 Neg
  • Mutated Citrullinated Vimentin (MCV) AB: <20
  • RNP Antibody: <1.0 Neg
  • Rheumatoid Factor (IgA): <5
  • Rheumatoid Factor (IgG): <5 IU/mL
  • Rheumatoid Factor (IgM): <5
  • Rheumatoid Factor (RF): <10 IU/mL
  • SCL-70 Antibody: <1.0 Neg
  • SM Antibody: <1.0 Neg
  • SM/RNP Antibody: <1.0 Neg
  • Sjogrens Antibody (SS-A): <1.0 Neg
  • Sjogrens Antibody (SS-B): <1.0 Neg

ANA Details

  • ANA Pattern: Nuclear, Homogeneous
  • ANA Titer: 1:1280

Blood (November 2, 2026)

Below Range

  • Hematocrit: 37.2%
  • Hemoglobin: 12.3 g/dL
  • Red Blood Cell Count: 3.97 Million/uL

In Range

  • MCH: 31.0 pg
  • MCHC: 33.1 g/dL
  • MCV: 93.7 fL
  • MPV: 10.3 fL
  • Platelet Count: 170 Thousand/uL
  • RDW: 13.9%
  • ABO Group: A
  • Rh Factor: Positive

Electrolytes

  • Calcium: 9.5 mg/dL
  • Carbon Dioxide: 29 mmol/L
  • Chloride: 102 mmol/L
  • Magnesium (RBC): 4.7 mg/dL
  • Potassium: 4.3 mmol/L
  • Sodium: 137 mmol/L

Environmental Toxins

  • Lead: 2.4 mcg/dL
  • Mercury: <5 mcg/L

Heart

Above Range

  • Apolipoprotein B (ApoB): 139 mg/dL
  • hs-CRP: 2.3 mg/L
  • LDL Medium: 669 nmol/L
  • LDL Particle Number: 2483 nmol/L
  • LDL Small: 344 nmol/L
  • LDL-Cholesterol: 157 mg/dL
  • Non-HDL Cholesterol: 171 mg/dL
  • Total Cholesterol: 249 mg/dL

Below Range

  • LDL Peak Size: 221.4 Angstrom

In Range

  • HDL Large: 13,000 nmol/L
  • HDL-Cholesterol: 78 mg/dL
  • LDL Pattern: A
  • Lipoprotein(a): 15 nmol/L
  • Total Cholesterol/HDL Ratio: 3.2
  • Triglycerides: 45 mg/dL

Immune Regulation

  • White Blood Cell Count: 4.6 Thousand/uL
  • Neutrophils: 2295 cells/uL (49.9%)
  • Lymphocytes: 1615 cells/uL (35.1%)
  • Monocytes: 414 cells/uL (9.0%)
  • Eosinophils: 244 cells/uL (5.3%)
  • Basophils: 32 cells/uL (0.7%)

Kidney

Above Range

  • Blood Urea Nitrogen (BUN): 37 mg/dL
  • BUN/Creatinine Ratio: 34

In Range

  • Creatinine: 1.09 mg/dL
  • eGFR: 64 mL/min/1.73m²
  • Albumin, Random Urine: 1.0 mg/dL

Liver

  • ALT: 20 U/L
  • AST: 23 U/L
  • Alkaline Phosphatase: 51 U/L
  • GGT: 10 U/L
  • Total Bilirubin: 0.6 mg/dL
  • Total Protein: 7.2 g/dL
  • Albumin: 4.0 g/dL
  • Globulin: 3.2 g/dL
  • Albumin/Globulin Ratio: 1.3

Male Health

  • PSA Total: 4.0 ng/mL
  • PSA Free: 1.3 ng/mL
  • PSA % Free: 33%
  • DHEA Sulfate: 56 mcg/dL
  • SHBG: 77 nmol/L
  • Testosterone, Free: 63.0 pg/mL
  • Testosterone, Total: 539 ng/dL
  • Estradiol (E2): <30 pg/mL
  • FSH: 14.3 mIU/mL
  • LH: 6.5 mIU/mL
  • Prolactin: 4.4 ng/mL

Metabolic

Above Range

  • Uric Acid: 8.1 mg/dL

In Range

  • Glucose: 84 mg/dL
  • HbA1c: 5.4%
  • Insulin: 2.1 uIU/mL
  • Leptin: 0.4 ng/mL

Nutrients

Above Range

  • Vitamin D: 106 ng/mL

Below Range

  • Omega-6 Linoleic Acid: 16.4% by weight

In Range

  • Ferritin: 105 ng/mL
  • Homocysteine: 14.2 umol/L
  • Iron: 135 mcg/dL
  • Iron Saturation: 41%
  • Iron Binding Capacity: 327 mcg/dL
  • Magnesium (RBC): 4.7 mg/dL
  • MMA: 93 nmol/L
  • Omega 6/3 Ratio: 3.7
  • Omega-3 Total: 7.6%
  • DHA: 4.2%
  • DPA: 1.4%
  • EPA: 2.0%
  • Arachidonic Acid: 9.1%
  • Zinc: 92 mcg/dL
  • Omega-6 Total: 28.2%
  • Arachidonic Acid/EPA Ratio: 4.7

Pancreas

  • Amylase: 47 U/L
  • Lipase: 19 U/L

Stress & Aging

  • Cortisol: 15.3 mcg/dL
  • DHEA Sulfate: 56 mcg/dL

Thyroid

  • Thyroglobulin Antibodies (TgAb): <2 IU/mL
  • Thyroid Peroxidase Antibodies (TPO): <1 IU/mL
  • TSH: 1.87 mIU/L
  • Free T4: 1.2 ng/dL
  • Free T3: 2.4 pg/mL

Urinalysis (November 2, 2026)

Out of Range

  • Appearance: Cloudy

In Range

  • Bilirubin: Negative
  • Color: Yellow
  • Glucose: Negative
  • Hyaline Casts: None Seen
  • Ketones: Negative
  • Leukocyte Esterase: Negative
  • Nitrite: Negative
  • Occult Blood: Negative
  • Protein: Negative
  • RBC: None Seen
  • WBC: None Seen
  • Specific Gravity: 1.008
  • pH: 5.5
  • Squamous Epithelial Cells: None Seen
  • Bacteria: None Seen

Source: Function Health Labs November 2026.pdf [Function H…ember 2026 | PDF]


Function Health Clinician Review

Your Strengths

  • Your metabolic health is outstanding: fasting glucose is 84 mg/dL, hemoglobin A1c is 5.4%, and fasting insulin is 2.1 uIU/mL, all supporting excellent blood sugar regulation and high insulin sensitivity.
  • HDL cholesterol remains robust at 78 mg/dL, providing strong cardiovascular protection, and triglycerides are at an optimal 45 mg/dL.
  • Liver function is excellent, with all enzyme and protein markers within both lab and optimal ranges, reflecting strong liver health and good nutritional status.
  • Electrolyte balance—including sodium, potassium, chloride, and calcium—is stable and in the optimal range, important for overall hydration, nerve, and muscle function.
  • White blood cell count and immune cell types (neutrophils, lymphocytes, monocytes, eosinophils, basophils) are all within healthy limits, showing a well-functioning immune system.

Areas that need your attention

  • You have mild, slowly progressive anemia: hemoglobin has dropped from 13.6 to 12.3 g/dL and hematocrit from 42.8% to 37.2%, with red blood cell count also declining. This should be discussed at a follow-up visit to determine the cause, as untreated anemia can impact energy and heart function.
  • LDL cholesterol (157 mg/dL), total cholesterol (249 mg/dL), and non-HDL cholesterol (171 mg/dL) all remain above recommended targets, though they have improved compared to prior values. Given your history of arrhythmia, hypertension, and cardiovascular procedures, these elevations still confer increased risk.
  • High-sensitivity C-reactive protein (hs-CRP) is elevated at 2.3 mg/L (optimal <1 mg/L), indicating persistent low-grade inflammation—though this is a substantial improvement from previous values (7.1 mg/L).
  • Blood urea nitrogen (BUN) and BUN/creatinine ratio are elevated and trending upward (BUN: 24 → 37 mg/dL; BUN/Cr ratio 33 → 34), likely reflecting your high-protein diet and possibly mild dehydration, but worth monitoring, especially as eGFR has declined over the past year (84 → 64 mL/min/1.73m²).
  • Free T3 thyroid hormone is at the lower end of the lab range (2.4 pg/mL), improved from prior lows but still below the optimal range, which may relate to your reported symptoms of cold intolerance and balance difficulty.

Connecting The Dots

  • The progressive anemia (declining hemoglobin and RBC) together with your age and chronic medical conditions suggests a multifactorial process—possibly involving chronic inflammation (elevated hs-CRP), nutritional factors, or age-related bone marrow changes.
  • Your high-protein, carnivore diet appears to contribute to elevated BUN and BUN/creatinine ratio, but kidney function remains adequate (creatinine and eGFR in range). This dietary pattern also aligns with excellent glucose control and lean BMI.
  • Persistent low-grade inflammation (hs-CRP 2.3 mg/L) links your cardiovascular risk profile (elevated LDL, hypertension, arrhythmia) with immune system activity and aging, emphasizing the importance of an integrated approach to managing inflammation. Elevated LDL particles can more easily penetrate the arterial wall, where they may become oxidized in the setting of chronic inflammation, triggering endothelial dysfunction, recruitment of inflammatory immune cells, and progressive plaque formation that underlies atherosclerosis.
  • Improvements in LDL, total cholesterol, and hs-CRP may reflect positive effects of your diet, supplements (omega-3s, vitamin D3), and regular exercise, but continued attention is warranted due to your history of heart rhythm issues and interventions.
  • Your thyroid function (free T3) has improved but remains suboptimal, which may contribute to symptoms of cold intolerance and balance difficulty—these are often interconnected with metabolic and inflammatory pathways.
  • Stable immune cell counts, good liver and electrolyte status, and absence of significant kidney or urinary abnormalities provide a solid foundation for resilience, but ongoing monitoring is important given your age, selective diet, and medical history.

Explore by Category

Blood

6 In Range
3 Out of Range

Your blood counts show several markers below the lab reference range, especially for red blood cells and oxygen-carrying capacity, with some further decline over time. Platelets remain stable and white blood cell counts are normal. This pattern points to mild, slowly worsening anemia that is clinically meaningful mainly for symptoms like fatigue and reduced exercise tolerance, rather than an immediate safety concern, most prominent in the drop in hemoglobin and hematocrit, with a parallel decrease in overall red blood cell count. Other red cell markers (MCV, MCH, MCHC, RDW) are within range and stable, suggesting a normocytic, normochromic anemia pattern. There are no signs of acute blood loss or a severe bone marrow problem, but this degree of anemia—especially in combination with your age, history of hypertension and arrhythmia, and prior cardiovascular procedures—warrants medical follow-up to clarify the underlying cause.

What it means for you

  • Hemoglobin and Hematocrit: Both are below the lab reference range (hemoglobin 12.3 g/dL, hematocrit 37.2%), with a trend of gradual decline over the past 18 months. Your hemoglobin has dropped from 13.6 to 12.3, and hematocrit from 42.8 to 37.2. This persistent and progressive pattern indicates mild anemia, which may contribute to symptoms like fatigue or weakness.
  • Red Blood Cell (RBC) Count: The RBC count is also below the lab reference range (3.97 million/uL), showing a steady decline over time. This further supports ongoing anemia.
  • Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemoglobin Concentration (MCHC), and Red Cell Distribution Width (RDW): These markers are within both lab and optimal ranges. Their stability suggests your anemia is not due to problems like iron deficiency, vitamin B12/folate deficiency, or significant cell-size variation.
  • Platelet Count and Mean Platelet Volume (MPV): Both are within range, stable, and do not suggest a bleeding or bone marrow issue.
  • Clinical significance: Mild, slowly progressive anemia in older adults can be due to chronic disease, nutritional gaps, kidney function changes, medication effects, or less commonly, bone marrow changes. Given your age, reported medical history (e.g., hypertension management), and your high-protein carnivore diet with a history of restrictive eating, further evaluation is recommended to assess for possible micronutrient gaps or effects of past disordered eating.

What to pay attention to

  • Progressive Anemia (Hemoglobin, Hematocrit, RBC): The continued drop in these values warrants follow-up with your primary care provider. While not immediately dangerous, untreated or unexplained anemia can impact energy, heart function, and overall resilience, and it is important to clarify the underlying cause.
  • Normocytic, Normochromic Pattern: Because your red blood cell size and hemoglobin content are normal, this narrows the likely causes (such as mild chronic inflammation, kidney function, or age-related marrow changes) rather than classic iron or vitamin deficiency.
  • Symptoms: If you experience worsening fatigue, shortness of breath, palpitations, dizziness, or new bleeding or bruising, these should be reported promptly to your doctor.

Connecting the dots

  • The pattern of anemia here can sometimes be seen in people with chronic conditions, kidney function changes, or low-grade inflammation. Your kidney function (creatinine and eGFR) is at the lower end of normal but not severely impaired (eGFR 64 mL/min/1.73m²).
  • Mildly elevated inflammation (hs-CRP 2.3 mg/L) may be a contributing factor and fits with age and chronic health conditions. Inflammatory signals in the body can reduce erythropoietin production in the kidneys and alter iron handling by trapping iron in storage sites, which limits red blood cell production and can lead to a normocytic anemia pattern.
  • Easy bruising, which you recently reported, can be linked to anemia and may reflect fragile blood vessels, medications, or subtle bleeding tendencies. Your platelet count is in range, which is reassuring, but this new symptom makes medical evaluation more important to address.

Out of range biomarkers:

Electrolytes

5 In Range

Your electrolyte panel shows stable results across sodium, potassium, chloride, calcium, and carbon dioxide. All values are in the lab reference range, and most also fall within the optimal range, suggesting good overall electrolyte and acid-base balance. Over the past year, there has been some variability—especially a brief drop in carbon dioxide that has since normalized—but there are no current signs of an acute or chronic electrolyte disturbance. These findings are especially reassuring in the context of your history of hypertension, heart rhythm issues, and ongoing potassium supplementation.

What it means for you

  • Sodium: Your sodium level is 137 mmol/L, stable over multiple tests and comfortably within the optimal and lab reference ranges. This supports good hydration and kidney function and suggests your dietary and medication factors (like antihypertensive therapy) are not causing sodium imbalance.
  • Potassium: At 4.3 mmol/L, your potassium remains well within both optimal and lab reference ranges, with a stable trend over the past year. This is important given your history of hypertension and ongoing potassium supplement use; no signs of low or high potassium are present.
  • Chloride: Your chloride level is 102 mmol/L, consistent and within all reference ranges. This further confirms stable fluid and acid-base regulation.
  • Calcium: Your calcium is 9.5 mg/dL, also steady and in-range over time. Healthy calcium balance is vital for bone, nerve, and muscle function.
  • Carbon Dioxide (Bicarbonate): Your carbon dioxide level is 29 mmol/L, returning to optimal and lab reference range after a prior drop to 18 mmol/L in June 2026. This suggests your acid-base balance has normalized, which is encouraging.

What to pay attention to

  • Acid-Base Balance Recovery: The prior low carbon dioxide value (18 mmol/L) in June 2026 could have reflected temporary changes in breathing, hydration status, or kidney function. The return to normal by November 2026 is reassuring, but if you noted any symptoms then (like weakness or confusion), it’s helpful to mention them at your next medical visit.
  • Electrolytes and Medications: With a history of hypertension, arrhythmia, and potassium supplementation, it’s important to continue monitoring these values in future labs, especially if your medication regimen changes or if you experience new symptoms like muscle cramps or irregular heartbeats.

Connecting the dots

  • The normalization of carbon dioxide aligns with stable kidney markers like creatinine and eGFR, supporting good kidney and metabolic health.
  • Your current potassium status remains optimal despite supplementation; this, along with stable kidney function, means your supplement dose is not leading to excess potassium.
  • Stable sodium and chloride, alongside a normal blood pressure medication profile, indicate your ongoing antihypertensive therapy (amlodipine) is not causing any electrolyte disturbances.
  • Your calcium is steady and in the optimal range, pairing with normal albumin and total protein, which supports healthy bone and nutritional status as you age.
Heart

3 In Range

4 Out of RAnge

Your heart health panel shows a mix of positive trends and ongoing areas for attention. Your HDL cholesterol remains robust and protective, and your triglycerides are in an optimal range, which are both strengths. However, your LDL cholesterol, total cholesterol, and non-HDL cholesterol remain above recommended targets, though all have improved compared to past results. Inflammation, as measured by hs-CRP, is still elevated but has improved markedly from 7.1 mg/L last year, then fluctuated in the 1.7–2.3 mg/L range. Your cholesterol/HDL ratio is favorable, indicating some balance between risk and protection. These results suggest progress—especially with inflammation and lipid levels—but continued monitoring and partnership with your care team are important.

What it means for you

  • HDL-Cholesterol: Your HDL (“good” cholesterol) is 78 mg/dL, well above both the lab reference (≥40 mg/dL) and the optimal target (≥60 mg/dL), showing strong cardiovascular protection. While it’s slightly lower than last year (previous range 82–92 mg/dL), it remains excellent.
  • Triglycerides: At 45 mg/dL, your triglycerides are not only within the lab reference (<150 mg/dL) but also in the optimal range (30–70 mg/dL). This suggests low risk for triglyceride-driven heart or metabolic disease and supports your overall lipid balance.
  • Total Cholesterol / HDL Ratio: Your ratio is 3.2, which is within the optimal range (<3.5) and well below the lab threshold (<5). This ratio reflects a healthy balance between protective and risk-promoting cholesterol particles.
  • LDL-Cholesterol, Total Cholesterol, Non-HDL Cholesterol: Your LDL is 157 mg/dL (lab target <100 mg/dL), total cholesterol is 249 mg/dL (lab target <200 mg/dL), and non-HDL cholesterol is 171 mg/dL (lab target <130 mg/dL). All are above recommended limits but have declined over the past year (for example, LDL from 186 to 157 mg/dL and total cholesterol from 290 to 249 mg/dL), indicating meaningful improvement.
  • High-Sensitivity C-Reactive Protein (hs-CRP): Your hs-CRP is 2.3 mg/L, which is still above the lab reference (0–1 mg/L) and optimal (<1 mg/L), reflecting ongoing low-grade inflammation. However, this has come down significantly from 7.1 mg/L last year, then fluctuated between 1.7 and 2.3 mg/L, showing substantial progress overall.

What to pay attention to

  • Elevated LDL, Total, and Non-HDL Cholesterol: While trending down, these remain above recommended levels and, together with your history of arrhythmia, hypertension, and prior cardiovascular interventions (pacemaker, ablation, Watchman device), warrant continued close monitoring and discussion with your cardiologist. Persistently high LDL and non-HDL cholesterol increase the risk for heart events, especially in those with existing heart rhythm or vascular issues.
  • Persistent but Improving Inflammation (hs-CRP): Your hs-CRP, a marker of systemic inflammation, remains mildly elevated. Chronic inflammation is a cardiovascular risk factor, so regular follow-up and efforts to address underlying contributors are important.
  • Ongoing Favorable HDL and Triglycerides: Your high HDL and optimal triglycerides are powerful positive factors that may help offset some cardiovascular risk, providing important protection for your heart and blood vessels.

Connecting the dots

  • Your improvements in LDL, total cholesterol, non-HDL cholesterol, and hs-CRP over the past year are consistent with possible benefits from lifestyle changes such as your reported high-protein, carnivore diet, regular exercise (4–5 times per week), and consistent supplement use (omega-3s, vitamin D3, magnesium, potassium). These positive trends are encouraging in the context of your preventive efforts and health goals focused on longevity, inflammation reduction, and healthy aging.
  • The combination of a strong HDL, optimal triglycerides, and favorable cholesterol/HDL ratio helps buffer against some of the risk associated with elevated LDL and total cholesterol. Your routine use of omega-3 supplements may be contributing to these results.
  • In the context of your personal history of arrhythmia, hypertension, and past heart procedures, the persistent elevation in LDL and inflammation highlights the ongoing importance of regular cardiovascular assessments. Collaboration with your cardiologist to review these trends and discuss any further evaluation or management options is recommended, especially given your age and history.
  • Your stable kidney function (creatinine 1.09 mg/dL, eGFR 64 mL/min/1.73m²), optimal blood glucose and HbA1c, and normal liver enzymes in complementary results provide further reassurance that your organs are handling your current dietary and supplement strategies well at this time.

Out of range biomarkers:

Immune Regulation

11 In Range

1 Out of Range

Your immune cell counts and inflammation markers show a generally well-functioning immune system, with steady white blood cell counts and immune cell types mostly in range. However, your high-sensitivity C-reactive protein (hs-CRP) remains above the reference range, signaling persistent low-grade inflammation with overall improvement from your prior peak level. Over time, your absolute counts for neutrophils, lymphocytes, eosinophils, monocytes, and basophils have all stayed within healthy limits, and trends suggest stable immune surveillance.

What it means for you

  • White Blood Cell (WBC) Count and Differential (Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils): Your total WBC count (4.6 thousand/uL) and all immune cell types by absolute count (neutrophils: 2295 cells/uL, lymphocytes: 1615 cells/uL, monocytes: 414 cells/uL, eosinophils: 244 cells/uL, basophils: 32 cells/uL) are within both lab reference and optimal ranges. These results indicate balanced immune cell production and no signs of acute infection or significant immune suppression. Your trends show stability, with only mild fluctuations expected over time and no abrupt changes.
  • High-Sensitivity C-Reactive Protein (hs-CRP): Your hs-CRP is 2.3 mg/L, which remains above the lab reference range (0–1 mg/L), but it has improved compared to prior values (7.1 mg/L and 1.8–1.7 mg/L in previous years). This pattern points to ongoing, low-level inflammation with an overall improvement from the prior peak but with a recent slight rise from 1.7–1.8 to 2.3 mg/L. Persistent mild elevation like this can reflect chronic inflammatory signals from various sources, such as underlying cardiovascular risk, metabolic signals, or environmental factors.
  • WBC Differential Percentages: Percentages for each immune cell type (e.g., neutrophils 49.9%, lymphocytes 35.1%) can shift with minor changes in total WBC; however, your absolute counts are the key markers of immune status, and these remain solidly in range.
  • Stability Across Time: All immune cells have shown minor, non-concerning fluctuations over the past year, with no abrupt rises or drops, and immune balance appears preserved. No cell type shows a sustained abnormal trend.
  • Eosinophils and Basophils: Your eosinophils and basophils, which can reflect allergic or environmental sensitivities, are in healthy ranges but show mild upward trends. This is consistent with your reported history of allergies and environmental sensitivities.

What to pay attention to

  • Ongoing Elevated hs-CRP: Your hs-CRP remains above the optimal and lab thresholds, suggesting a persistent low-grade inflammatory state. This can be associated with chronic cardiovascular, metabolic, or allergic/inflammatory signals, especially in the context of your history of hypertension, arrhythmia, elevated cholesterol, and ongoing environmental allergies. The improving trend is positive, but ongoing monitoring and evaluation for contributors to inflammation is warranted.
  • Allergy-Related Immune Cell Trends: Mild increases in eosinophils and basophils, along with your reported allergies and environmental sensitivities, suggest that your immune system is experiencing ongoing mild activation in response to environmental or dietary allergens. At present, absolute counts remain well within healthy limits.
  • Stable WBC and Differential: The stability of all immune cell types over time, with no evidence of suppression or overactivation, is a reassuring sign of balanced immune regulation, particularly important given your history of melanoma and chronic inflammatory conditions.

Connecting the dots

  • The persistently elevated but improving hs-CRP level, combined with a background of cardiovascular conditions (hypertension, arrhythmia, elevated cholesterol) and ongoing environmental and food allergies, highlights a chronic inflammatory burden that is likely influenced by both metabolic/cardiovascular and immune/allergic pathways.
  • The stability and healthy range of your WBC, neutrophils, lymphocytes, monocytes, eosinophils, and basophils suggest that while inflammation is present (as shown by hs-CRP), your immune system is not showing signs of overt infection, blood cell abnormalities, or immune suppression.
  • Complementary lab results show stable kidney function (creatinine and eGFR), normal liver enzymes (ALT, AST, ALP), and solid nutritional markers (albumin, total protein), all of which support the interpretation that your immune activation is not due to organ dysfunction or acute systemic disease.

Out of range biomarkers:

Kidney

6 In Range
2 Out of Range

Your kidney function results show several key findings. Most of your core kidney-related markers—including creatinine, eGFR, sodium, potassium, calcium, and urinalysis—are within the lab reference range, which is reassuring. However, there are upward trends and out-of-range values in your blood urea nitrogen (BUN) and BUN/creatinine ratio that suggest increased protein breakdown or dehydration. Your eGFR has decreased over time but remains above the lab’s threshold for concern, and your creatinine is stable. No evidence of kidney inflammation, infection, or significant protein loss appears in your urine studies.

What it means for you

  • Blood Urea Nitrogen (BUN) and BUN/Creatinine Ratio: Your BUN is elevated at 37 mg/dL (lab range: 7–25), and the BUN/creatinine ratio is also high at 34 (lab range: 6–22). Both have increased compared to prior results (BUN: 24 → 30 → 27 → 37; BUN/Cr: 33 → 26 → 34), indicating a persistent and rising trend. Elevated BUN and ratio without corresponding creatinine rise often reflect higher dietary protein intake, mild dehydration, or other non-kidney causes, especially in the absence of clinical symptoms or urine abnormalities.
  • Creatinine and eGFR: Your creatinine remains in the lab reference range at 1.09 mg/dL (range: 0.70–1.22), with stable readings over the past several draws. Your eGFR is 64 mL/min/1.73m², down from 84 one year ago but stable since June (68). For your age, this is not unexpected; eGFR tends to decline with aging, but your value remains above the lab’s threshold for chronic kidney concerns (≥60).
  • Electrolytes (Sodium, Potassium, Chloride, Calcium): All are in the lab reference range and show no concerning shifts. This suggests ongoing stable fluid and electrolyte balance.
  • Urinalysis (Protein, Blood, WBC, Bacteria, Casts): No evidence of proteinuria, hematuria, leukocytes, or infection in your urine. This supports the absence of significant kidney inflammation or damage.
  • Urine Appearance: A single occurrence of cloudy urine was found, but with no other abnormal findings or infection signals, this is not clinically concerning.

What to pay attention to

  • Rising BUN and High BUN/Creatinine Ratio: The persistent and increasing elevation of BUN and BUN/creatinine ratio, in the absence of creatinine rise or urine abnormalities, warrants monitoring. In your context—high-protein (carnivore) diet and possible mild dehydration—these results are most likely related to lifestyle rather than kidney disease. If you develop symptoms such as fatigue, swelling, changes in urination, or confusion, you should discuss this with your healthcare provider.
  • Gradual Decline in eGFR: Your eGFR has decreased over a year (84 → 82 → 68 → 64), which can be part of normal aging, but it is important to keep monitoring, especially given your history of hypertension and heart rhythm issues. If eGFR falls significantly below 60 or you develop new symptoms, this warrants additional evaluation.

Connecting the dots

  • The elevated BUN and BUN/creatinine ratio are likely related to your high-protein, carnivore diet, as reported in your background, and possibly mild dehydration. This dietary approach can increase nitrogen waste products (BUN) even when kidney function (creatinine, eGFR) is stable.
  • A gradual reduction in kidney filtering capacity, reflected by lower eGFR together with higher BUN, can increase the buildup of metabolic waste products and contribute to vascular stiffness, higher blood pressure load, and low-grade inflammation, which in turn can feed back into cardiovascular risk, especially in the setting of preexisting hypertension or heart rhythm issues.
  • No evidence of kidney inflammation or infection is present, as complementary urinalysis markers—including protein, blood, leukocytes, and bacteria—are consistently negative, providing reassurance against acute or chronic kidney disease.
  • Your stable creatinine and electrolyte markers support the impression of preserved kidney filtering function, with the main signals being dietary and age-related rather than disease-driven.

Out of range biomarkers:

Liver

8 In Range

Your liver biomarkers are all within both the lab reference range and the optimal range, and have stayed stable over several years. This pattern suggests robust liver function and protein balance. No current signs of liver stress, damage, or protein imbalance are evident in your results.

What it means for you

  • Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP): All liver enzymes are well within their respective lab reference and optimal ranges, and have shown stable values over time. This is a strong sign that your liver cells are healthy, with no evidence of ongoing liver injury or inflammation.
  • Albumin, Globulin, Albumin/Globulin Ratio, Total Protein: These protein markers are within both lab and optimal ranges and remain within range, with modest declines in albumin and total protein that appear clinically insignificant at this time. This means your liver is synthesizing proteins effectively and that your nutritional status appears good.
  • Total Bilirubin: Your bilirubin remains in the midpoint of the reference range across tests. This indicates normal processing and clearance of red blood cell breakdown products, with no bile flow obstruction or hemolysis detected.

What to pay attention to

  • Stable Liver Markers: Your consistently normal liver panel suggests effective liver function and no current evidence of acute or chronic liver disease.
  • Protein Balance: Steady albumin, globulin, and total protein levels support adequate nutrition and proper liver synthetic function.

Connecting the dots

  • Your good liver health aligns with your report of excellent overall health and a protein-rich diet, supporting optimal protein synthesis and metabolic function.
  • Kidney markers in your complementary results (e.g., creatinine and eGFR) are also in the lab reference range, and urine tests show no protein, bilirubin, or blood, reinforcing the pattern of healthy liver and kidney function.
  • Your ongoing use of supplements such as vitamin D, magnesium, and omega-3s, along with a home-cooked, high-protein diet, may be helping to sustain your liver and metabolic health.
Metabolic

3 In Range

Your metabolic health panel shows stable blood sugar control, very low fasting insulin, and an optimal body weight by BMI, all of which support healthy metabolic function. Glucose and hemoglobin A1c remain in both the optimal and reference ranges, with minimal fluctuation over time. Fasting insulin is at the lower end of normal and within the optimal range, reflecting high insulin sensitivity. These patterns are consistent with a lean body composition and a nutrition approach focused on protein and intermittent fasting as described in your background.

What it means for you

  • Glucose: Your fasting glucose is 84 mg/dL, in both the lab reference range (65–99 mg/dL) and optimal range (70–85 mg/dL). This value is stable compared to previous draws and has remained well controlled over the past 18 months. Stable glucose at this level reduces risk for unwanted blood sugar spikes and helps protect vascular health.
  • Hemoglobin A1c (HbA1c): Your A1c is 5.4%, within the lab reference range (<5.7%) and optimal range (4.8–5.5%). This reflects your average blood glucose over the past two to three months and confirms consistent blood sugar control. No significant trend up or down has been seen, suggesting durable metabolic stability.
  • Insulin: Your fasting insulin is 2.1 uIU/mL, well below the lab upper limit (≤18.4 uIU/mL) and at the very low end of the optimal range (2–5 uIU/mL). This indicates your body is highly sensitive to insulin and does not need to produce much to keep your blood sugar stable. Over the past year, your insulin has stayed low, without any recent increase.
  • BMI: Your BMI is 20.95, which is within the healthy range for adults and supports your reported weight and body composition goals. A BMI in this range is associated with reduced metabolic and cardiovascular risk.

What to pay attention to

  • Stable, optimal glucose and insulin: The combination of a fasting glucose near 84 mg/dL and insulin of 2.1 uIU/mL, with a BMI of 20.95, reflects high insulin sensitivity and healthy metabolic flexibility. Continued trends in this pattern are reassuring, particularly in the context of aging.
  • A1c stability: Absence of any upward drift in A1c over time is notable given your age and risk factors. This pattern supports your preventive efforts and suggests current nutrition and lifestyle strategies are effective.

Connecting the dots

  • Your strong metabolic control (glucose 84 mg/dL, HbA1c 5.4%, insulin 2.1 uIU/mL, BMI 20.95) aligns with your high-protein, intermittent fasting, and carnivore dietary approach. This likely underpins your reported stable body weight and excellent energy, even in your ninth decade.
  • The consistently low fasting insulin, in context with a lean BMI and stable glucose, suggests that your current diet and exercise habits are helping maintain optimal insulin sensitivity and blood sugar stability.
  • Background reports of regular physical activity, excellent sleep, and avoidance of alcohol and caffeine further reinforce your metabolic resilience and long-term health trajectory.
Nutrients

All Markers in Range

Your calcium level is steady and sits comfortably within both the lab reference and optimal ranges, indicating stable regulation of this important mineral. Over the past year, your calcium has shown no concerning shifts or trends, which speaks to good bone and metabolic balance. There are no out-of-range or borderline findings for calcium at this time.

What it means for you

  • Calcium: Your current value is 9.5 mg/dL, which is solidly within both the lab reference range (8.6–10.3 mg/dL) and the optimal range (8.6–10.3 mg/dL). This is consistent with your values over the past year (9.7, 10.1, and 9.6 mg/dL), demonstrating stable calcium balance with no significant upward or downward trends.
  • Trend stability: The ongoing stability of your calcium readings, with all results falling well within the healthy and optimal ranges, suggests consistent dietary intake, good kidney function, and effective hormonal regulation of calcium. No signs of either high (hypercalcemia) or low (hypocalcemia) calcium are present.
  • No evidence of imbalance: There are no sudden changes or out-of-range results that would point to bone loss, parathyroid gland issues, or nutritional deficits. Your calcium status appears optimal for overall metabolic and bone health.

What to pay attention to

  • Stable calcium with no concerning changes: Consistent, in-range readings mean your current dietary pattern and supplementation are supporting robust calcium metabolism.
  • No urgent findings: No results suggest an acute or progressive issue that would require prompt evaluation.

Connecting the dots

  • Your steady calcium levels, together with complementary metabolic and kidney markers (such as normal albumin at 4 g/dL and in-range creatinine at 1.09 mg/dL), reinforce effective kidney function and a balanced nutritional approach, despite your highly selective carnivore-based diet. This indicates your current lifestyle is supporting healthy calcium homeostasis and metabolic health.
Thyroid

All Markers In Range

Your thyroid biomarker, free Triiodothyronine (T3), has returned to the lab reference range after previously being low. This improvement reflects a positive trend in your thyroid hormone status, which is important given your long-term use of levothyroxine. While your T3 is now in the normal range, it remains below the optimal range for longevity and health optimization, which may be especially relevant considering your age and history of symptoms like cold intolerance and balance difficulty.

What it means for you

  • Triiodothyronine (T3) Free: Your current T3 Free level is 2.4 pg/mL (lab reference range: 2.3–4.2 pg/mL; optimal: 3–4.4 pg/mL). This is within the lab reference range but still below the optimal target. Over the past year, your T3 was out of range and has now shown improvement: from 2.1 pg/mL (June 2025, out of range) to 2.4 pg/mL now. This positive trend suggests better thyroid hormone availability. Low-normal levels may contribute to symptoms such as cold intolerance and difficulty with balance, which you have reported.

What to pay attention to

  • T3 Free below optimal, persistent hypothyroid symptoms: Even though your T3 Free is in the lab reference range, your value is still below the optimal range for health optimization. Since you report symptoms like cold intolerance and balance problems, this level may not be fully meeting your metabolic needs. Ongoing symptoms, despite lab values in range, warrant a discussion with your healthcare provider about further thyroid evaluation and possible dose adjustment of your levothyroxine.

Connecting the dots

  • T3 Free and levothyroxine use: Your long-term use of levothyroxine for thyroid support aligns with the observed improvements in T3 Free, but persistent symptoms suggest your current thyroid hormone replacement may need further optimization.
  • T3 Free and metabolic/energy status: Your optimal body weight, regular exercise pattern, and good dietary habits are all supportive for thyroid health, but persistent low-normal T3 can still contribute to energy, temperature regulation, and balance symptoms.
  • T3 Free and inflammation: Your high-sensitivity C-reactive protein (hs-CRP) remains above the lab reference range at 2.3 mg/L. Chronic inflammation can sometimes blunt thyroid hormone conversion and function by increasing inflammatory cytokines such as IL-6, which can impair peripheral conversion of T4 to the active T3 hormone and reduce thyroid hormone receptor signaling in tissues. This makes it important to address both thyroid levels and inflammatory status together.
Urine

15 Markers in range
1 Out of range

Cloudy urine was observed on your most recent test, even though all other urine findings were within healthy ranges and consistent with past results. There were no signs of infection, kidney injury, or metabolic imbalance, and markers such as protein, blood, glucose, and white blood cells remained normal. The trace ketones seen previously are now resolved, and your urine pH, specific gravity, and color are all in the expected range.

What it means for you

  • Appearance – Urine: Your urine was cloudy this time, which is a change from prior tests where it was always clear. Occasional cloudiness can result from harmless causes like diet, minor dehydration, or the presence of harmless crystals, especially in the absence of infection or other abnormal findings.
  • Leukocyte Esterase – Urine, Nitrite – Urine, White Blood Cell (WBC) – Urine, Bacteria – Urine: All remained negative or none seen, ruling out a urinary tract infection at this time.
  • Protein – Urine, Glucose – Urine, Occult Blood – Urine, Red Blood Cell (RBC) – Urine: These were all negative or none seen, indicating no signs of kidney injury, bleeding, or diabetes-related changes.
  • Ketones – Urine: Previously, a trace amount of ketones was present, likely reflecting your reported dietary habits (carnivore, intermittent fasting). Current testing shows resolution, suggesting dietary patterns may shift ketone presence.
  • pH – Urine, Specific Gravity – Urine, Color – Urine: All parameters remain steady and within reference and optimal ranges, supporting well-hydrated status and healthy kidney function.

What to pay attention to

  • Cloudy Urine with Otherwise Normal Markers: The isolated finding of cloudy urine, with all infection and kidney injury markers negative, is reassuring and often benign. If you notice persistent changes in urine appearance, pain, or new urinary symptoms, these would warrant a discussion with your healthcare provider, especially given your age and history of urinary symptoms.

Connecting the dots

  • The resolved trace ketones in your urine likely reflect your high-protein and intermittent fasting dietary pattern. As your dietary routine changes, mild shifts in urine chemistry (such as temporary ketonuria or cloudiness) can occur. Given your normal kidney function markers (creatinine, eGFR) and no evidence of protein or blood in the urine, these findings are not of concern at this time.

Out of range biomarkers:

Return to Laboratory Library index
Return to Master Index

2027 4 Reports

7.2 Laboratory Trends & Analysis

7.2.0 Topics

Purpose

The purpose of this section is to analyze laboratory results over time to identify health trends, improvements, recurring patterns, unresolved questions, and areas requiring continued monitoring.

Unlike Section 7.1, which preserves individual laboratory reports, Section 7.2 focuses on the relationship between laboratory results across multiple years.

This section provides a longitudinal view of:

  • Disease progression
  • Recovery
  • Lifestyle impact
  • Current health status
  • Future monitoring priorities

Overview

The laboratory history from 2021 through 2026 documents a remarkable health journey.

The major transition points include:


2021 — Severe Systemic Inflammatory Illness

Major findings:

  • Markedly elevated inflammatory markers.
  • Normocytic anemia.
  • Significant decline in overall health.
  • Extensive diagnostic evaluation initiated.

2022 — Recovery and Diagnostic Investigation

Major findings:

  • Inflammation improved.
  • Blood counts recovered.
  • Autoimmune and mast cell evaluations performed.
  • Multiple possible causes excluded.

2023 — Recurrence of Anemia and Expanded Evaluation

Major findings:

  • Mild normocytic anemia returned.
  • Iron deficiency excluded.
  • Nutritional deficiencies excluded.
  • Autoimmune disease not demonstrated as active.
  • Recovery occurred without specific anemia treatment.

2024 — Lifestyle Transformation

Major findings:

  • Strict carnivore diet initiated January 1, 2024.
  • Significant improvement in inflammation.
  • Improved metabolic markers.
  • Favorable triglyceride and HDL pattern.
  • Continued anemia monitoring.

2025–2026 — Advanced Preventive Health Monitoring

Major findings:

  • Advanced Function Health testing added.
  • Persistent autoimmune markers identified.
  • Excellent metabolic health documented.
  • Cardiovascular risk evaluated in greater depth.
  • Current health baseline established.

Category Index

Category Trends

7.2.1 Inflammation Trends

Purpose

The purpose of this section is to document the progression of systemic inflammation from the severe inflammatory illness experienced in 2021 through recovery and the current state of inflammatory control in 2026.

Inflammation is the central thread connecting many parts of your Health Inventory:

  • The severe illness beginning in 2021.
  • The development of normocytic anemia.
  • The extensive autoimmune investigation.
  • The recovery process.
  • The impact of lifestyle changes beginning in 2024.
  • The current state of health optimization.

The primary laboratory markers used to evaluate this trend are:

  • C-Reactive Protein (CRP)
  • Erythrocyte Sedimentation Rate (ESR)

Overview

The laboratory record documents a dramatic change in inflammatory status over five years.

In 2021, laboratory testing showed clear evidence of significant systemic inflammation:

  • ESR was markedly elevated.
  • CRP was markedly elevated.
  • Normocytic anemia developed.
  • Overall health declined significantly.

Through extensive medical evaluation and time, the inflammatory markers gradually normalized.

By 2024–2026, laboratory evidence demonstrates:

  • Very low CRP.
  • Normal ESR.
  • No evidence of active systemic inflammation.

The overall trend demonstrates:

Severe systemic inflammation → diagnostic investigation → gradual resolution → sustained inflammatory control.


Key Inflammatory Markers

C-Reactive Protein (CRP)

What It Measures

CRP is a protein produced by the liver in response to inflammation.

It is commonly used to assess:

  • Acute inflammation.
  • Infection.
  • Autoimmune activity.
  • Cardiovascular inflammatory risk.

CRP Trend

DateCRP ResultSignificance
October 202132 mg/LSevere inflammatory elevation
July 20226 mg/LSignificant improvement
June 20242 mg/LLow inflammatory activity
November 20241 mg/LExcellent inflammatory control

CRP Interpretation

The CRP trend demonstrates one of the clearest improvements in the entire Health Inventory.

2021

CRP of 32 mg/L indicated significant systemic inflammation.

This correlated with:

  • Severe illness.
  • Elevated ESR.
  • Anemia.
  • Decline in physical condition.

2022

CRP decreased substantially.

This corresponded with:

  • Recovery of blood counts.
  • Improvement in symptoms.
  • Extensive evaluation showing no active infectious or autoimmune cause.

2024–2026

CRP remained very low.

This indicates:

  • No evidence of ongoing systemic inflammation.
  • Strong inflammatory control.
  • Significant improvement compared with the 2021 illness.

Erythrocyte Sedimentation Rate (ESR)

What It Measures

ESR measures how quickly red blood cells settle in a tube of blood.

It is a nonspecific marker that may increase with:

  • Inflammation.
  • Infection.
  • Autoimmune disease.
  • Chronic inflammatory conditions.

ESR Trend

DateESR ResultSignificance
October 202171 mm/hrSevere inflammatory response
July 202213 mm/hrMajor improvement
September 202327 mm/hrWithin reference range
June 20266 mm/hrExcellent inflammatory control

ESR Interpretation

The ESR trend closely parallels the CRP trend.

The dramatic reduction from:

71 → 6 mm/hr

is one of the strongest objective measures of recovery.

The current ESR indicates:

  • No laboratory evidence of active systemic inflammation.
  • No evidence of ongoing inflammatory disease activity.
  • Continued monitoring remains appropriate because of persistent autoimmune markers.

Relationship Between Inflammation and Other Health Trends

1. Inflammation and Anemia

During the 2021 inflammatory illness:

  • CRP increased.
  • ESR increased.
  • Hemoglobin decreased.

This pattern is consistent with anemia occurring during systemic inflammation.

The later resolution of inflammation was followed by recovery of blood counts.


2. Inflammation and Autoimmune Testing

The Health Inventory demonstrates an important distinction:

Autoimmune markers:

Still present.

Active inflammation:

Not present.

Current pattern:

  • ANA positive.
  • ESR normal.
  • CRP very low.
  • No disease-specific antibodies identified.

This distinction is important for future rheumatology discussions.


3. Inflammation and Lifestyle Changes

Beginning January 1, 2024:

  • Strict carnivore diet initiated.
  • Joint and muscle symptoms improved.
  • Laboratory inflammation markers continued improving.

While laboratory results cannot prove that one factor caused the improvement, the timing demonstrates a strong association between lifestyle changes and improved inflammatory status.


Current Status (2026)

Inflammatory Health Assessment

AreaStatus
CRPExcellent
ESRExcellent
Active systemic inflammationNo evidence
Autoimmune markersPersistent, monitoring appropriate
Previous inflammatory illnessResolved

Overall Interpretation

The inflammation trend represents one of the most successful outcomes documented in the Health Inventory.

The laboratory evidence shows:

  • A severe inflammatory state in 2021.
  • Gradual normalization through 2022.
  • Sustained inflammatory control through 2026.

The most accurate summary is:

The inflammatory illness that significantly affected health in 2021 has resolved, with current laboratory evidence showing excellent inflammatory control. Persistent autoimmune markers remain an important area for observation but are not accompanied by evidence of active inflammatory disease.

Return to Category-Index
Return to Main Inventory


7.2.2 Autoimmune Trends

Purpose

The purpose of this section is to analyze the progression of autoimmune-related laboratory findings over time and to distinguish between:

  • Evidence of immune system activation
  • Evidence of active autoimmune disease
  • Evidence of resolved or controlled inflammatory illness

The autoimmune laboratory history is one of the most important discoveries within the Health Inventory because it provides a clearer understanding of the relationship between your 2021 inflammatory illness and your current health status.

The primary markers reviewed include:

  • Antinuclear Antibody (ANA)
  • ANA Titer
  • ANA Pattern
  • Rheumatoid Factor (RF)
  • Anti-CCP Antibody
  • Anti-dsDNA Antibody
  • Extractable Nuclear Antigen (ENA) antibodies
  • Inflammatory markers (ESR and CRP) as supporting evidence

Overview

The autoimmune laboratory story has evolved over several years.

The pattern is not one of progressive autoimmune disease. Instead, the record shows:

  1. A severe inflammatory illness in 2021.
  2. Extensive autoimmune evaluation during and after the illness.
  3. Initial absence of definitive autoimmune disease markers.
  4. Later identification of persistent ANA positivity.
  5. Continued absence of disease-specific autoimmune antibodies.
  6. Resolution of inflammatory activity.

The current picture is:

Persistent autoimmune serology without laboratory evidence of active systemic autoimmune disease.


1. Antinuclear Antibody (ANA)

What ANA Measures

ANA testing detects antibodies that react against components within the body’s own cells.

A positive ANA may occur with:

  • Systemic autoimmune diseases.
  • Previous immune activation.
  • Certain infections.
  • Medications.
  • Some healthy individuals, particularly with increasing age.

A positive ANA alone does not establish an autoimmune diagnosis.


ANA Trend

DateResultSignificance
September 2023NegativeNo detectable ANA at that time
June 2025PositiveAutoimmune serology identified
November 2025PositivePersistent finding confirmed
June 2026PositivePersistent finding confirmed

Interpretation

The most recent testing demonstrates that ANA positivity is persistent.

However, ANA must be interpreted with:

  • Symptoms.
  • Physical findings.
  • Disease-specific antibodies.
  • Inflammatory markers.

In your case:

Positive:

  • ANA
  • Homogeneous Pattern

Negative:

  • dsDNA
  • Smith
  • RNP
  • SSA
  • SSB
  • CCP
  • Rheumatoid Factor

2. ANA Titer Trend

Findings

June 2025

  • ANA Titer: 1:320

June 2026

  • ANA Titer: 1:1280

Interpretation

The increase in ANA titer is an important finding.

However, the clinical significance depends on the entire picture.

The higher ANA titer is not accompanied by:

  • Elevated ESR.
  • Elevated CRP.
  • Abnormal kidney function.
  • Abnormal blood counts.
  • Disease-specific autoantibodies.

Therefore, the titer increase represents:

Increased detectable autoimmune antibody activity, but not evidence by itself of active autoimmune disease.

This distinction is very important.


3. ANA Pattern

Finding

Homogeneous Nuclear Pattern


Interpretation

The homogeneous pattern is commonly associated with antibodies directed against nuclear components.

It may be seen in:

  • Lupus-related conditions.
  • Drug-induced autoimmune responses.
  • Other autoimmune states.

However, the pattern alone cannot establish a diagnosis.

The absence of supporting antibody markers and inflammatory activity remains important.


4. Disease-Specific Autoimmune Antibodies

Anti-dsDNA

Result

Negative

Significance

Anti-dsDNA antibodies are strongly associated with systemic lupus erythematosus, particularly disease activity involving kidneys.

Current finding:

  • No laboratory evidence supporting lupus.

Smith Antibody

Result

Negative

Significance

Smith antibodies are highly specific for lupus.

Current finding:

  • No laboratory evidence supporting lupus.

RNP Antibody

Result

Negative

Significance

Associated with mixed connective tissue disease.

Current finding:

  • No laboratory evidence supporting this condition.

SSA / SSB Antibodies

Result

Negative

Significance

Associated with Sjögren’s syndrome and certain lupus patterns.

Current finding:

  • No laboratory evidence supporting these disorders.

CCP Antibody

Result

Negative

Significance

Associated with rheumatoid arthritis.

Current finding:

  • No laboratory evidence supporting rheumatoid arthritis.

Rheumatoid Factor (RF)

Result

Negative

Significance

Supports the absence of serologic evidence for rheumatoid arthritis.


5. Relationship Between Autoimmunity and Inflammation

This is the most important interpretation in your case.

Earlier Pattern (2021)

Autoimmune concern:

  • Severe symptoms.
  • Elevated ESR.
  • Elevated CRP.
  • Anemia.
  • Significant decline.

Current Pattern (2026)

Autoimmune markers:

  • ANA positive.
  • High titer.

Inflammation:

  • ESR 6.
  • CRP very low.
  • Normal blood counts.

Current Interpretation

The laboratory pattern has changed from:

Active inflammatory illness with immune activation

to:

Persistent immune markers without active inflammation

This is a significant distinction.


6. Autoimmune Trend Summary

CategoryHistorical FindingCurrent Status
ANABecame positivePersistent
ANA TiterIncreasedMonitor
ANA PatternHomogeneousPersistent
RFNegativeRemains negative
CCPNegativeRemains negative
dsDNANegativeRemains negative
ENA PanelNegativeRemains negative
ESRPreviously elevatedNormal
CRPPreviously elevatedVery low

Overall Interpretation

The autoimmune trend demonstrates a complex but reassuring pattern:

  • A significant immune event occurred in 2021.
  • ANA positivity has persisted and increased over time.
  • However, there is no current laboratory evidence of active systemic autoimmune disease.
  • Inflammation remains controlled.
  • Blood counts and organ function are normal.

The most accurate summary is:

The immune system shows evidence of prior and ongoing autoimmune activity, but current laboratory findings do not demonstrate active autoimmune disease. Continued monitoring with clinical correlation is appropriate.

Return to Category-Index
Return to Main Inventory


7.2.3 Blood Health Trends

Purpose

The purpose of this section is to analyze changes in blood health over time, with particular attention to:

  • Hemoglobin
  • Hematocrit
  • Red blood cell count
  • Red blood cell indices
  • White blood cell patterns
  • Platelet counts
  • Iron status
  • Vitamin status

The primary focus is the history of normocytic anemia that developed during the 2021 inflammatory illness, recurred during 2023–2024, and ultimately resolved by 2026.


Overview

The laboratory record documents a clear pattern:

  1. Significant inflammatory illness in 2021.
  2. Development of normocytic anemia.
  3. Extensive evaluation to identify possible causes.
  4. Temporary recurrence of anemia in 2023–2024.
  5. Gradual spontaneous recovery.
  6. Normal blood counts by June 2026.

The overall trend demonstrates:

Inflammation-associated blood changes followed by complete hematologic recovery.


1. Hemoglobin Trend

What Hemoglobin Measures

Hemoglobin is the protein within red blood cells responsible for carrying oxygen throughout the body.

Low hemoglobin may result from:

  • Blood loss
  • Iron deficiency
  • Vitamin deficiency
  • Kidney disease
  • Bone marrow disorders
  • Chronic inflammation
  • Autoimmune processes

Hemoglobin Trend

DateHemoglobinInterpretation
2021 inflammatory illness~11–12 g/dLReduced during illness
December 202213.8 g/dLRecovery
June 202312.3 g/dLMild decline
July 202311.8 g/dLMild anemia
September 202311.3 g/dLAnemia present
November 202313.1 g/dLRecovery
June 202411.2 g/dLRecurrence
August 202411.3 g/dLStable
November 202412.6 g/dLImprovement
June 202613.6 g/dLNormal

Interpretation

The hemoglobin pattern is one of the strongest recovery indicators in the Health Inventory.

The trend shows:

  • Decline during inflammatory illness.
  • Temporary improvement.
  • Recurrence without evidence of nutritional deficiency.
  • Gradual normalization.

The final value:

Hemoglobin 13.6 g/dL (June 2026)

represents complete recovery.


2. Type of Anemia

Historical Pattern

The anemia was classified as:

Normocytic anemia

Meaning:

  • Red blood cell size remained normal.
  • Cells were not abnormally small or large.

Why This Matters

Normocytic anemia often points away from:

  • Iron deficiency anemia
  • Vitamin B12 deficiency
  • Folate deficiency

and toward possibilities such as:

  • Inflammation-related anemia
  • Chronic disease states
  • Temporary suppression during illness
  • Recovery following systemic stress

3. Iron Status

Key Laboratory Findings

Iron studies demonstrated:

  • Normal iron levels.
  • Normal ferritin.
  • Normal iron saturation.

Interpretation

The laboratory record does not support iron deficiency as the cause of anemia.

This was an important diagnostic finding because iron deficiency is one of the most common causes of anemia.


4. Vitamin B12 and Folate Status

Findings

Repeated testing demonstrated:

  • Adequate Vitamin B12.
  • Adequate Folate.

Interpretation

The anemia was not explained by nutritional deficiency.

This is particularly important because your diet changed significantly in 2024, yet blood counts improved rather than declined.


5. White Blood Cell Trends

Purpose

White blood cells provide information about:

  • Infection.
  • Immune activity.
  • Bone marrow function.

Findings

Throughout the laboratory record:

  • White blood cell counts remained generally normal.
  • No persistent leukopenia was identified.
  • No evidence of generalized bone marrow suppression was found.

Interpretation

The isolated nature of the anemia was reassuring.

The pattern was:

  • Red blood cells affected.
  • White blood cells preserved.
  • Platelets preserved.

This argues against a broad bone marrow disorder.


6. Platelet Trends

Findings

Platelet counts remained normal throughout monitoring.


Interpretation

Normal platelet production supports preserved bone marrow function.


7. Eosinophil Trend

An additional blood finding occurred during 2024.

June 2024

Findings:

  • Eosinophils elevated.
  • Absolute eosinophils elevated.

November 2024

Findings:

  • Eosinophils improved substantially.

Interpretation

The temporary eosinophilia resolved without evidence of progressive immune or hematologic disease.


Blood Health Summary Table

CategoryHistorical FindingCurrent Status
HemoglobinReduced during illnessNormal
HematocritReducedNormal
RBC CountReduced during anemiaNormal
MCVNormalNormal
IronAdequateAdequate
FerritinAdequateAdequate
B12AdequateAdequate
FolateAdequateAdequate
WBCPreservedNormal
PlateletsPreservedNormal
EosinophilsTemporarily elevatedImproved

Relationship to Other Health Trends

Blood Health and Inflammation

The strongest connection is between inflammation and anemia.

The timeline:

2021

Inflammation ↑
↓
Hemoglobin ↓

↓

2024–2026

Inflammation ↓
↓
Hemoglobin ↑

This relationship strongly suggests that inflammation played a significant role in the anemia pattern.


Blood Health and Autoimmunity

Although autoimmune markers remain positive:

  • No autoimmune blood disorder has been demonstrated.
  • Blood counts are currently normal.
  • Inflammatory markers are normal.

Current Status (2026)

Hematologic Health Assessment

AreaStatus
HemoglobinExcellent
AnemiaResolved
Iron statusNormal
Nutritional causesExcluded
Bone marrow concernNo evidence
Monitoring needContinue routine surveillance

Physician Discussion Points

Questions for Dr. George

  1. Given the complete recovery of hemoglobin, should CBC monitoring continue quarterly with the planned laboratory schedule?
  2. Is there any additional evaluation needed if anemia returns?
  3. Should iron studies remain part of periodic monitoring?

Questions for Dr. Saifi

  1. Could the prior anemia have been related to systemic inflammation during the 2021 illness?
  2. Does the current normal blood profile provide reassurance regarding autoimmune disease activity?

Overall Interpretation

The blood health trend represents one of the strongest recovery stories in the Health Inventory.

The laboratory record demonstrates:

  • A period of anemia associated with severe systemic illness.
  • Extensive evaluation excluding common nutritional causes.
  • Gradual improvement.
  • Complete normalization by June 2026.

The most accurate summary is:

The normocytic anemia appears to have been associated with the prior inflammatory illness and has resolved, with current laboratory evidence demonstrating normal blood production and excellent hematologic recovery.


Related Sections

This trend analysis connects directly with:


Return to Main Inventory

7.2.4 Cardiovascular Trends

Cardiovascular Trends

Purpose

Section 7.2.4 — Cardiovascular Trends


Purpose

The purpose of this section is to analyze cardiovascular-related laboratory trends over time and evaluate the interaction between:

  • Traditional lipid markers
  • Advanced cardiovascular markers
  • Inflammation
  • Metabolic health
  • Blood pressure history
  • Cardiac history

The goal is not simply to identify individual abnormal values but to understand the complete cardiovascular risk profile.

The primary markers reviewed include:

  • Total cholesterol
  • LDL cholesterol
  • HDL cholesterol
  • Triglycerides
  • Non-HDL cholesterol
  • Cholesterol/HDL ratio
  • ApoB
  • LDL particle number
  • Lipoprotein(a)
  • hs-CRP
  • Glucose regulation markers

Overview

Your cardiovascular laboratory history reveals a distinctive pattern that has remained consistent over several years:

Favorable Cardiovascular Factors

  • Very high HDL cholesterol.
  • Very low triglycerides.
  • Excellent glucose control.
  • Very low inflammatory markers.
  • Strong insulin sensitivity.
  • Low Lipoprotein(a).

Areas Requiring Continued Evaluation

  • Elevated LDL cholesterol.
  • Elevated ApoB.
  • Elevated LDL particle number.
  • History of hypertension.
  • History of atrial fibrillation.
  • Ascending aortic aneurysm monitoring.

The most accurate summary is:

A favorable metabolic and inflammatory profile with persistent LDL-related cardiovascular risk factors requiring individualized evaluation.


1. Traditional Lipid Trends

Total Cholesterol

Trend
DateTotal Cholesterol
2023~249 mg/dL
June 2024220 mg/dL
November 2024243 mg/dL
December 2025256 mg/dL
June 2026284 mg/dL

Interpretation

Total cholesterol has generally increased since 2024.

However, total cholesterol alone does not fully describe cardiovascular risk because it includes:

  • LDL cholesterol
  • HDL cholesterol
  • Other cholesterol particles

The complete lipid pattern must be considered.


2. LDL Cholesterol Trend

What LDL Represents

LDL cholesterol is a measure of cholesterol carried within LDL particles.

Elevated LDL has been associated with increased cardiovascular risk, particularly when associated with elevated particle number.


LDL Trend

DateLDL Cholesterol
2023~151 mg/dL
June 2024136 mg/dL
November 2024141 mg/dL
December 2025151 mg/dL
June 2026183 mg/dL

Interpretation

LDL cholesterol has remained elevated and increased in the most recent Function Health assessment.

This is the primary cardiovascular issue requiring continued evaluation.

Important considerations:

  • LDL is only one component of cardiovascular risk.
  • LDL should be interpreted with ApoB, particle number, inflammation, metabolic health, and clinical history.

3. HDL Cholesterol Trend

What HDL Represents

HDL cholesterol is commonly associated with reverse cholesterol transport and has traditionally been considered protective.


HDL Trend

DateHDL
June 202475
November 202494
December 202589
June 202682

Interpretation

HDL has remained exceptionally high.

This is one of the most consistent favorable findings in your cardiovascular profile.


4. Triglyceride Trend

Trend

DateTriglycerides
June 202450
November 202452
December 202560
June 202685

Interpretation

Triglycerides have remained very favorable.

Low triglycerides generally correlate with:

  • Improved insulin sensitivity.
  • Lower metabolic risk.
  • Improved metabolic flexibility.

5. Cholesterol/HDL Ratio

Trend

DateRatio
December 20252.9

Interpretation

The cholesterol/HDL ratio remains favorable.

This demonstrates why your cardiovascular profile requires a complete assessment rather than focusing on LDL alone.


6. Advanced Cardiovascular Markers

ApoB

Purpose

ApoB estimates the number of potentially atherogenic particles in circulation.

It may provide additional risk information beyond LDL cholesterol.


Finding

June 2026:

  • ApoB elevated.

Interpretation

The elevated ApoB is an important finding because it suggests increased numbers of cholesterol-containing particles.

This should be discussed with Dr. Yoo.


LDL Particle Number

Purpose

LDL particle number measures the number of LDL particles rather than simply the cholesterol contained within them.


Finding

June 2026:

  • LDL particle number elevated.

Interpretation

This reinforces that LDL-related risk deserves attention beyond the standard lipid panel.


Lipoprotein(a)

Finding

Lipoprotein(a) remains low.


Interpretation

This is a favorable cardiovascular finding.

Elevated Lipoprotein(a) is an inherited cardiovascular risk factor; your results do not show this additional risk factor.


7. Inflammation and Cardiovascular Risk

One of the strongest positive trends in your cardiovascular profile is inflammation control.

Relevant markers:

  • CRP: decreased from 32 (2021) to 1–2 range.
  • ESR: decreased from 71 to 6.

Interpretation

Low inflammation is an important favorable cardiovascular factor.

Your current cardiovascular profile includes:

✅ Low inflammatory activity
✅ Excellent metabolic health
✅ Favorable triglycerides
✅ High HDL


8. Metabolic Factors Affecting Cardiovascular Health

Key Findings

  • HbA1c approximately 5.4–5.5%.
  • Low fasting insulin.
  • Low leptin.
  • Normal glucose regulation.

Interpretation

Your metabolic markers suggest excellent insulin sensitivity.

This is an important protective factor.


9. Relationship to Cardiac History

Laboratory trends must be interpreted with your medical history.

Important cardiovascular conditions:

Hypertension

History:

  • Previously treated with Amlodipine.
  • Blood pressure became low enough that medication reduction was required.

Current consideration:

  • Continued blood pressure monitoring is important.

Atrial Fibrillation

History:

  • Prior atrial fibrillation.
  • Watchman implant.
  • Eliquis discontinued after Watchman management.

Current consideration:

  • Cardiovascular risk assessment should include rhythm history.

Ascending Aortic Aneurysm

History:

  • Requires continued imaging surveillance.

Current consideration:

  • Blood pressure control remains important.

Current Cardiovascular Assessment (2026)

CategoryStatus
LDL cholesterolRequires attention
ApoBElevated
LDL particle numberElevated
HDLExcellent
TriglyceridesExcellent
Lipoprotein(a)Favorable
InflammationExcellent
Glucose controlExcellent
Insulin sensitivityExcellent
Blood pressureRequires monitoring
Cardiac historyRequires continued follow-up

Physician Discussion Points

Questions for Dr. Yoo — Cardiology

1. Given the elevated LDL, ApoB, and LDL particle number, how should cardiovascular risk be interpreted in the context of:

  • Very low inflammation?
  • Excellent triglycerides?
  • High HDL?
  • Excellent metabolic markers?

2. Would additional evaluation be helpful?

Examples:

  • Coronary artery calcium scoring (if appropriate).
  • Additional imaging.
  • Repeat advanced lipid testing.

3. What LDL/ApoB targets are appropriate given:

  • Age.
  • Cardiac history.
  • Atrial fibrillation history.
  • Aortic aneurysm monitoring.

4. Should lipid-lowering therapy be reconsidered or adjusted?


Questions for Dr. George — Primary Care

  1. Should advanced lipid testing continue annually?
  2. Should ApoB become a routine monitoring marker?
  3. How should cardiovascular trends be integrated with the quarterly laboratory schedule?

Overall Interpretation

The cardiovascular laboratory story is one of balance.

Your profile demonstrates:

Major Strengths

  • Excellent metabolic health.
  • Very low inflammation.
  • Very high HDL.
  • Very low triglycerides.
  • Low Lipoprotein(a).

Areas Requiring Continued Attention

  • Elevated LDL cholesterol.
  • Elevated ApoB.
  • Elevated LDL particle number.
  • Cardiovascular history.

The most accurate summary is:

A metabolically healthy cardiovascular profile with persistent LDL-related risk factors requiring individualized cardiology evaluation and ongoing monitoring.


Related Sections

This trend analysis connects directly with:

Return to Main Inventory

7.2.5 Metabolic Trends

Metabolic Trends

Purpose

The purpose of this section is to analyze laboratory markers related to metabolic health over time, including:

  • Blood glucose regulation
  • Insulin sensitivity
  • Hemoglobin A1c
  • Fasting insulin
  • Leptin
  • Ketone metabolism
  • Glucose-to-ketone relationship

The goal is to understand how metabolic health has changed through:

  • The 2021 inflammatory illness.
  • Recovery.
  • Lifestyle changes beginning January 1, 2024.
  • Current preventive health monitoring.

Overview

The metabolic laboratory record demonstrates a significant improvement in metabolic health over time.

The overall pattern shows:

  1. Stable glucose control during and after recovery.
  2. Mild elevation of A1c during earlier years.
  3. Improvement after major lifestyle changes.
  4. Excellent insulin sensitivity documented through advanced testing.

The current metabolic picture is:

Excellent glucose regulation with strong insulin sensitivity and favorable metabolic markers.


1. Fasting Glucose Trends

What Glucose Measures

Blood glucose reflects the amount of circulating sugar available for energy.

Elevated glucose may indicate:

  • Insulin resistance.
  • Prediabetes.
  • Diabetes risk.
  • Metabolic dysfunction.

Glucose Trend

DateGlucoseInterpretation
Earlier laboratory testingGenerally normalStable glucose regulation
November 202487 mg/dLNormal
November 202593 mg/dLNormal
June 202666 mg/dLLow-normal

Interpretation

Glucose values have remained within a favorable range.

The June 2026 value of 66 mg/dL should be interpreted in context:

  • Excellent insulin sensitivity markers.
  • No evidence of glucose instability.
  • Consistent with low-carbohydrate nutritional patterns.

2. Hemoglobin A1c Trends

What A1c Measures

Hemoglobin A1c estimates average blood glucose exposure over approximately three months.

It is commonly used to assess:

  • Prediabetes.
  • Diabetes risk.
  • Long-term glucose control.

A1c Trend

DateA1cInterpretation
January 20225.6%Normal
December 20225.7%Borderline elevation
June 20235.6%Normal
September 20235.8%Elevated
August 20245.4%Improved
November 20245.8%Mild elevation
June 20265.5%Normal

Interpretation

The A1c trend demonstrates improvement.

Important observations:

  • No progression toward diabetes.
  • Values remain near normal.
  • Improvement followed major dietary changes.

The current A1c of 5.5% represents a favorable metabolic state.


3. Insulin Trends

What Insulin Measures

Insulin is produced by the pancreas to help move glucose into cells.

High insulin levels may indicate:

  • Insulin resistance.
  • Metabolic stress.
  • Increased diabetes risk.

Key Findings

Function Health testing demonstrated:

November 2025
  • Insulin: 4.6
June 2026
  • Insulin: 2.1

Interpretation

The insulin trend is one of the strongest metabolic indicators in your record.

The reduction suggests:

  • Improved insulin sensitivity.
  • Lower metabolic demand.
  • Efficient glucose utilization.

4. Leptin Trends

What Leptin Measures

Leptin is a hormone involved in:

  • Appetite regulation.
  • Energy balance.
  • Fat metabolism.

Higher leptin levels may be associated with:

  • Increased body fat.
  • Leptin resistance.
  • Metabolic dysfunction.

Findings

November 2025

  • Leptin: 1.1

June 2026

  • Leptin: 0.4

Interpretation

The low leptin values are consistent with:

  • Low insulin levels.
  • Favorable metabolic flexibility.
  • Reduced metabolic inflammation.

5. Ketone Metabolism and GKI

Personal Metabolic Data

Your Health Inventory includes an important personal metabolic measurement:

January 4, 2026 — After 24-hour fast

Results:

  • Glucose: 78 mg/dL
  • Ketones: 4.7 mmol/L
  • GKI: 0.9

Interpretation

A GKI below 1 indicates a strong ketogenic state.

This measurement demonstrates:

  • Effective fat metabolism.
  • Ability to transition between fuel sources.
  • Strong metabolic flexibility.

6. Relationship Between Diet and Metabolic Health

Lifestyle Change

Beginning:

January 1, 2024

Diet:

  • Strict carnivore diet.
  • Beef.
  • Eggs.
  • Butter.
  • Salt.
  • Raw whole milk.

Observed Laboratory Changes

Following this transition:

Inflammation

CRP continued decreasing.

Glucose

A1c improved.

Insulin

Insulin levels became very low.

Triglycerides

Remained exceptionally low.

Symptoms

Reported improvement:

  • Resolution of severe inflammation.
  • Resolution of joint and muscle pain.

7. Metabolic Health and Aging

Metabolic health is closely connected with:

  • Cardiovascular risk.
  • Inflammation.
  • Biological aging.
  • Longevity.

Your advanced testing shows:

Positive markers:

✅ Low insulin
✅ Low leptin
✅ Normal A1c
✅ Favorable triglycerides
✅ Excellent glucose regulation


Current Metabolic Assessment (2026)

CategoryStatus
Fasting glucoseExcellent
A1cNormal
InsulinExcellent
LeptinExcellent
Insulin resistanceNo evidence
Metabolic syndromeNo evidence
Ketone metabolismStrong

Physician Discussion Points

Questions for Dr. George

  1. Should fasting insulin become part of routine monitoring?
  2. How should low glucose values be interpreted given excellent metabolic markers and dietary patterns?
  3. Should A1c continue to be monitored quarterly?

Questions for Dr. Yoo

  1. How should excellent metabolic markers influence cardiovascular risk interpretation?
  2. Does improved insulin sensitivity modify overall cardiovascular assessment?

Overall Interpretation

The metabolic trend represents one of the strongest success stories in the Health Inventory.

The laboratory record demonstrates:

  • Stable glucose regulation.
  • Improved A1c.
  • Very low insulin levels.
  • Favorable metabolic hormone profile.
  • Strong ketogenic flexibility.

The most accurate summary is:

Current metabolic health is excellent, with laboratory evidence of strong insulin sensitivity and favorable glucose regulation following significant lifestyle changes beginning in 2024.


Related Sections

This trend analysis connects directly with:

  • Section 6 — Lifestyle & Health Goals
  • Section 7.2.4 — Cardiovascular Trends
  • Section 7.2.6 — Kidney Function Trends
  • Section 7.2.9 — Aging and Longevity Markers
  • Section 9 — Current Supplements & Diet Notes

Stephen, this section is important because it documents measurable evidence behind something you have repeatedly described: you changed your approach to eating for health rather than pleasure, and the laboratory record shows a corresponding improvement in several metabolic markers.

7.2.6 Kidney Function Trends

Kidney Function Trends

Purpose

The purpose of this section is to analyze kidney-related laboratory trends over time and evaluate:

  • Kidney filtration function.
  • Hydration-related markers.
  • Protein metabolism indicators.
  • Evidence of kidney injury or disease.

The primary markers reviewed include:

  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Blood Urea Nitrogen (BUN)
  • BUN/Creatinine Ratio
  • Urinalysis findings

Overview

The laboratory record demonstrates stable and preserved kidney function throughout the Health Inventory.

The major findings are:

  • Creatinine has remained normal.
  • eGFR has remained in a healthy range.
  • Urinalysis has remained normal.
  • No evidence of protein loss or kidney damage has been identified.
  • BUN has occasionally been elevated, likely influenced by dietary protein intake.

The overall kidney health summary is:

Preserved kidney filtration with no laboratory evidence of kidney disease. Elevated BUN values appear to require interpretation within the context of high protein intake and hydration status rather than reduced kidney function.


1. Creatinine Trends

What Creatinine Measures

Creatinine is a waste product produced by normal muscle metabolism.

It is commonly used to estimate kidney filtration.

Higher creatinine levels may indicate reduced kidney function.


Creatinine Trend

DateCreatinineInterpretation
June 20240.92 mg/dLNormal
November 20240.88 mg/dLNormal
2025 Function Health testingNormalPreserved function
June 2026NormalPreserved function

Interpretation

Creatinine has remained stable and within normal limits.

This is one of the most important indicators that kidney filtration has remained intact.


2. Estimated Glomerular Filtration Rate (eGFR)

What eGFR Measures

eGFR estimates how effectively the kidneys filter blood.

Generally:

  • Higher values indicate better filtration.
  • Lower values may indicate reduced kidney function.

eGFR Trend

DateeGFRInterpretation
June 202481Normal kidney function
November 202483Normal kidney function
June 2026PreservedStable

Interpretation

The eGFR trend demonstrates:

  • Stable kidney filtration.
  • No progressive decline.
  • No evidence of chronic kidney disease.

For an older adult, maintaining this level of kidney function is a significant positive health marker.


3. Blood Urea Nitrogen (BUN) Trends

What BUN Measures

BUN measures the amount of urea nitrogen in the blood.

Urea is produced when the body breaks down protein.

BUN may increase due to:

  • High protein intake.
  • Dehydration.
  • Fasting.
  • Reduced kidney filtration.

BUN Trend

DateBUNInterpretation
June 202440 mg/dLElevated
November 202433 mg/dLElevated
Later testingMonitoredStable

Interpretation

The elevated BUN values are important but should not be interpreted alone.

In your case, the elevated BUN occurs with:

  • Normal creatinine.
  • Normal eGFR.
  • Normal urinalysis.

This pattern generally suggests increased protein metabolism rather than kidney failure.


4. BUN/Creatinine Ratio

Findings

The BUN/Creatinine ratio has been elevated.


Interpretation

A high BUN/Creatinine ratio can occur with:

  • High protein intake.
  • Increased meat consumption.
  • Lower fluid intake.
  • Fasting.

Your dietary pattern includes:

  • High animal protein intake.
  • Low carbohydrate intake.
  • Periodic fasting.

Therefore, this marker should be interpreted in that context.


5. Urinalysis Trends

Purpose

Urinalysis provides information about:

  • Protein leakage.
  • Blood loss.
  • Infection.
  • Kidney damage.

Findings

Repeated urinalysis has shown:

Normal:

  • No protein.
  • No blood.
  • No glucose.
  • No infection markers.

Interpretation

Normal urinalysis is an important reassuring finding.

There is no laboratory evidence of:

  • Kidney injury.
  • Protein loss.
  • Urinary tract disease.

6. Kidney Function and Carnivore Diet

Lifestyle Context

Beginning January 2024:

Diet:

  • Beef.
  • Eggs.
  • Butter.
  • Salt.
  • Raw whole milk.

This represents a significantly higher protein and animal-food intake compared with a typical diet.


Laboratory Response

Observed:

Positive:

✅ Normal creatinine
✅ Preserved eGFR
✅ Normal urinalysis
✅ Stable kidney function

Finding requiring interpretation:

⚠ Elevated BUN


Current Interpretation

The laboratory pattern does not suggest kidney damage.

The most likely explanation for the BUN elevation is:

  • Increased protein metabolism.
  • Dietary protein load.
  • Hydration differences.

Continued monitoring remains appropriate.


Kidney Health Summary Table

CategoryHistorical FindingCurrent Status
CreatinineNormalNormal
eGFRPreservedPreserved
BUNOccasionally elevatedMonitor
BUN/Creatinine RatioElevatedInterpret with diet
UrinalysisNormalNormal
Kidney disease evidenceNoneNone

Relationship to Other Health Trends

Kidney Health and Metabolic Health

The combination of:

  • Low insulin.
  • Normal glucose.
  • Low inflammation.
  • Preserved kidney function.

suggests excellent metabolic health.


Kidney Health and Diet

The laboratory record provides an opportunity to monitor how a high-protein dietary pattern affects kidney markers over time.

Future quarterly testing will be valuable.


Current Kidney Assessment (2026)

AreaStatus
FiltrationExcellent
Kidney injury markersNone identified
Protein leakageNone
Hydration markersMonitor
Long-term monitoringAppropriate


Overall Interpretation

The kidney trend represents another strong area of health stability.

The laboratory record demonstrates:

  • Normal creatinine.
  • Preserved eGFR.
  • Normal urinalysis.
  • No evidence of kidney damage.

The only recurring finding is elevated BUN, which appears consistent with increased protein metabolism rather than impaired kidney function.

The most accurate summary is:

Kidney function remains excellent, with preserved filtration and no evidence of kidney disease. Elevated BUN values should continue to be monitored but interpreted in the context of dietary protein intake and hydration status.


Related Sections

This trend analysis connects directly with:

7.2.7 Thyroid Trends

Thyroid Trends

Purpose

The purpose of this section is to analyze thyroid-related laboratory trends over time and evaluate:

  • Effectiveness of thyroid replacement therapy.
  • Stability of thyroid function.
  • Relationship between TSH, Free T4, and Free T3.
  • Potential areas for physician discussion.

The primary markers reviewed include:

  • Thyroid-Stimulating Hormone (TSH)
  • Free Thyroxine (Free T4)
  • Free Triiodothyronine (Free T3)
  • Thyroid antibodies

Overview

The thyroid laboratory record demonstrates stable thyroid replacement control over time.

The overall pattern shows:

  • Normal TSH values.
  • Normal Free T4 values.
  • Persistent lower Free T3 levels on advanced testing.
  • Negative thyroid antibody testing.

The current thyroid picture is:

Thyroid replacement therapy is maintaining normal standard thyroid markers, while the lower Free T3 pattern remains an area for continued monitoring and physician discussion.


1. Thyroid History

Condition

Hypothyroidism

Current Treatment

  • Levothyroxine 75 mcg daily in the morning.

Clinical Goal

The purpose of thyroid replacement therapy is to maintain adequate thyroid hormone availability and prevent symptoms associated with low thyroid function.

Monitoring generally includes:

  • TSH.
  • Free T4.
  • Clinical symptoms.

2. Thyroid-Stimulating Hormone (TSH)

What TSH Measures

TSH is produced by the pituitary gland and regulates thyroid hormone production.

A normal TSH generally indicates appropriate thyroid hormone feedback regulation.


TSH Trend

DateTSHInterpretation
June 20240.819 μIU/mLNormal
November 20241.110 μIU/mLNormal
2025 Function HealthNormalStable
June 2026NormalStable

Interpretation

TSH has remained consistently controlled.

This suggests:

  • Appropriate thyroid hormone replacement.
  • Stable pituitary-thyroid regulation.
  • No evidence of under-treatment or significant over-treatment.

3. Free T4 Trend

What Free T4 Measures

Free T4 represents the circulating available form of thyroxine, the primary hormone produced by the thyroid gland and replaced with levothyroxine.


Free T4 Trend

DateFree T4Interpretation
June 20241.31 ng/dLNormal
November 20241.24 ng/dLNormal
2025 TestingNormalStable
June 2026NormalStable

Interpretation

Free T4 has remained in a healthy range.

This supports the conclusion that levothyroxine therapy is effectively maintaining thyroid hormone availability.


4. Free T3 Trend

What Free T3 Measures

Free T3 is the active thyroid hormone used by tissues throughout the body.

The body converts T4 into T3 through metabolic processes.


Findings

Advanced Function Health testing identified:

  • Free T3 below the reference range.

This finding has persisted despite:

  • Normal TSH.
  • Normal Free T4.

Interpretation

The Free T3 pattern is an important observation.

Possible explanations may include:

  • Individual variation in thyroid hormone conversion.
  • Effects of calorie restriction or fasting.
  • Low-carbohydrate nutritional patterns.
  • Metabolic adaptation.
  • Age-related changes.

This finding should be interpreted together with:

  • Symptoms.
  • Energy level.
  • Body temperature.
  • Heart rate.
  • Overall clinical status.

5. Thyroid Antibodies

Testing Included

  • Thyroid Peroxidase Antibodies (TPO)
  • Thyroglobulin Antibodies

Findings

  • Thyroid antibodies negative.

Interpretation

The absence of thyroid antibodies suggests no current laboratory evidence of autoimmune thyroid destruction.

This is important given the broader autoimmune evaluation.


6. Relationship Between Thyroid and Other Health Trends

Thyroid and Metabolic Health

Your thyroid results should be viewed alongside:

  • Excellent glucose control.
  • Low insulin levels.
  • Low inflammation.
  • Stable weight/metabolic status.

The laboratory picture does not suggest impaired metabolic health.


Thyroid and Cardiovascular Health

Because thyroid hormones influence:

  • Heart rhythm.
  • Cholesterol metabolism.
  • Cardiovascular function.

continued monitoring is appropriate, especially given your history of:

  • Atrial fibrillation.
  • Cardiovascular follow-up with Dr. Yoo.

Thyroid and Autoimmunity

The broader autoimmune picture shows:

  • Positive ANA.
  • Negative thyroid antibodies.

This suggests that the ANA finding is not explained by autoimmune thyroid disease.


Thyroid Summary Table

CategoryHistorical FindingCurrent Status
HypothyroidismEstablished diagnosisManaged
Levothyroxine75 mcg dailyContinued
TSHNormalControlled
Free T4NormalControlled
Free T3LowerMonitor
Thyroid antibodiesNegativeNo evidence of thyroid autoimmunity

Current Thyroid Assessment (2026)

AreaStatus
Thyroid replacementEffective
TSH controlExcellent
Free T4Excellent
Free T3 conversionMonitor
Autoimmune thyroid diseaseNot demonstrated


Overall Interpretation

The thyroid trend demonstrates stable and effective management of hypothyroidism.

The laboratory record shows:

  • Normal TSH.
  • Normal Free T4.
  • Negative thyroid antibodies.
  • Persistent lower Free T3 requiring observation.

The most accurate summary is:

Thyroid replacement therapy is providing excellent standard laboratory control. The persistent lower Free T3 pattern represents an area for continued monitoring and discussion but is not accompanied by evidence of thyroid instability.


Related Sections

This trend analysis connects directly with:

7.2.8 Nutritional Trends

Nutritional Trends

Purpose

The purpose of this section is to analyze nutritional laboratory trends over time and evaluate:

  • Vitamin status.
  • Mineral status.
  • Iron availability.
  • Protein-related nutrition.
  • Fatty acid balance.
  • Supplement effectiveness.
  • Nutritional adequacy during dietary changes.

The primary markers reviewed include:

  • Vitamin B12
  • Folate
  • Iron
  • Ferritin
  • Iron saturation
  • Magnesium
  • Zinc
  • Omega-3 status
  • Methylmalonic acid (MMA)
  • Homocysteine
  • Vitamin D
  • Other nutrient-related markers

Overview

The nutritional laboratory record demonstrates that your nutritional status has remained strong through a significant dietary transition beginning January 1, 2024.

The major themes are:

  1. Nutritional deficiencies have not been identified.
  2. Iron status has remained adequate.
  3. Vitamin B12 and folate levels have remained sufficient.
  4. Mineral status has generally remained favorable.
  5. Advanced testing has provided additional insight into long-term nutritional health.

The current nutritional picture is:

Excellent nutritional status with continued monitoring appropriate because of dietary uniqueness, age, and long-term health goals.


1. Iron Status Trends

Why Iron Matters

Iron is essential for:

  • Hemoglobin production.
  • Oxygen transport.
  • Energy metabolism.

Iron deficiency is one of the most common causes of anemia.


Key Findings

Throughout the anemia evaluation:

  • Iron levels remained adequate.
  • Ferritin remained normal.
  • Iron saturation remained normal or favorable.

Example:

June 2024

  • Iron: 121 µg/dL
  • Ferritin: 152 ng/mL
  • Iron saturation: 48%

Interpretation

The laboratory evidence does not support iron deficiency as the cause of the previous anemia.

This was an important diagnostic conclusion.

The anemia pattern was more consistent with:

  • Inflammation-related anemia.
  • Temporary systemic illness effects.

Current Status

CategoryStatus
Iron storesAdequate
FerritinNormal
Iron deficiencyNot demonstrated

2. Vitamin B12 Trends

Why Vitamin B12 Matters

Vitamin B12 supports:

  • Red blood cell production.
  • Neurologic function.
  • DNA synthesis.

Low B12 may cause:

  • Macrocytic anemia.
  • Neurologic symptoms.

Key Findings

Repeated testing demonstrated strong B12 levels.

Examples:

June 2024

  • Vitamin B12: 1,208 pg/mL

November 2024

  • Vitamin B12: 1,062 pg/mL

Interpretation

B12 status has remained excellent.

The anemia was not caused by B12 deficiency.


Current Status

CategoryStatus
B12 levelExcellent
Deficiency evidenceNone

3. Folate Trends

Why Folate Matters

Folate supports:

  • Red blood cell formation.
  • DNA production.
  • Cell growth.

Key Findings

Examples:

June 2024

  • Folate: 11.9 ng/mL

November 2024

  • Folate: 9.7 ng/mL

Interpretation

Folate status remains adequate.

No evidence suggests folate deficiency contributed to anemia.


4. Magnesium Trends

Importance

Magnesium supports:

  • Muscle function.
  • Nerve function.
  • Heart rhythm.
  • Electrolyte balance.

Key Findings

Laboratory magnesium levels remained normal.

Supplement history:

  • Magnesium glycinate: 240 mg daily.

Interpretation

Magnesium status appears well maintained.

This is particularly relevant because of:

  • Cardiovascular history.
  • Atrial fibrillation history.
  • Electrolyte management.

5. Zinc Trends

Importance

Zinc supports:

  • Immune function.
  • Wound healing.
  • Hormone function.

Trend

November 2024

  • Zinc: 121 µg/dL (slightly elevated)

June 2026

  • Zinc normalized.

Interpretation

The mild elevation was not associated with adverse findings.

Normalization suggests appropriate balance.


6. Omega-3 Status

Importance

Omega-3 fatty acids support:

  • Cardiovascular health.
  • Inflammation regulation.
  • Cell membrane function.

Findings

Function Health testing included:

  • OmegaCheck.
  • EPA.
  • DHA.
  • Omega ratios.

Results demonstrated:

  • Favorable omega-3 status.

June 2026:

  • Omega-3 Index: 7.6%

Interpretation

This represents a favorable nutritional marker.

It supports:

  • Balanced fatty acid status.
  • Reduced inflammatory tendency.

7. Methylmalonic Acid (MMA)

Importance

MMA helps evaluate functional Vitamin B12 status.


Findings

MMA remained normal.


Interpretation

This confirms that B12 availability is adequate at the cellular level.


8. Homocysteine

Importance

Homocysteine is involved in:

  • Methylation pathways.
  • Cardiovascular risk assessment.
  • Nutritional status evaluation.

Findings

Homocysteine remained within acceptable range.


Interpretation

This supports adequate:

  • B12 status.
  • Folate status.
  • Metabolic function.

9. Vitamin D

Importance

Vitamin D affects:

  • Bone health.
  • Immune regulation.
  • Muscle function.

Finding

Vitamin D levels have remained elevated.


Interpretation

Because supplementation and dietary intake can significantly influence Vitamin D levels, continued monitoring is appropriate.

The goal is maintaining an appropriate range rather than simply maximizing the number.


10. Relationship Between Nutrition and Diet

Lifestyle Change

Beginning January 1, 2024:

Diet:

  • Beef.
  • Eggs.
  • Butter.
  • Salt.
  • Raw whole milk.

Laboratory Response

The nutritional record demonstrates:

Positive findings:

✅ Adequate iron
✅ Excellent B12
✅ Adequate folate
✅ Stable minerals
✅ Favorable omega-3 status
✅ Excellent metabolic markers


Nutritional Summary Table

CategoryHistorical FindingCurrent Status
IronAdequateAdequate
FerritinNormalNormal
B12StrongStrong
FolateAdequateAdequate
MagnesiumNormalNormal
ZincMild elevationNormalized
Omega-3FavorableFavorable
MMANormalNormal
HomocysteineNormalNormal
Vitamin DElevatedMonitor

Current Nutritional Assessment (2026)

AreaStatus
Protein nutritionExcellent
Vitamin statusExcellent
Mineral statusGood
Iron statusExcellent
Nutritional deficienciesNone identified
Long-term monitoringAppropriate


Overall Interpretation

The nutritional trend demonstrates strong nutritional health despite a major dietary transition.

The laboratory evidence shows:

  • No evidence of nutritional deficiency.
  • Adequate micronutrient status.
  • Strong iron availability.
  • Favorable fatty acid profile.
  • Good metabolic support.

The most accurate summary is:

The current nutritional profile demonstrates excellent nutrient sufficiency and supports the broader pattern of improved metabolic health, reduced inflammation, and recovery documented throughout the Health Inventory. Continued monitoring remains appropriate because of the uniqueness of the dietary approach and long-term health goals.


Related Sections

This trend analysis connects directly with:

7.2.9 Aging and Longevity Markers

Aging and Longevity Markers

Purpose

The purpose of this section is to analyze laboratory and health indicators associated with healthy aging, functional longevity, and overall biological resilience.

Unlike traditional disease-focused testing, longevity assessment examines:

  • How well the body is functioning.
  • How effectively metabolic systems are operating.
  • Whether inflammation is controlled.
  • Whether nutritional needs are being met.
  • Whether organ systems remain strong.

The major longevity indicators reviewed include:

  • Biological age assessment.
  • Inflammatory markers.
  • Metabolic health.
  • Cardiovascular risk markers.
  • Hormonal health.
  • Nutritional status.
  • Kidney and organ function.

Overview

The Health Inventory documents a significant transformation over the past five years.

The laboratory story progresses from:

2021

A period of:

  • Severe systemic inflammation.
  • Reduced physical condition.
  • Anemia.
  • Significant decline in overall health.

↓

2024–2026

A period characterized by:

  • Very low inflammation.
  • Normal blood counts.
  • Excellent metabolic markers.
  • Strong nutritional status.
  • Preserved organ function.
  • Advanced preventive monitoring.

The overall longevity assessment is:

Current laboratory findings demonstrate multiple markers associated with healthy aging, including excellent metabolic health, low inflammation, preserved organ function, and strong nutritional status.


1. Biological Age Assessment

Purpose

Biological age attempts to estimate the functional age of the body based on multiple health indicators rather than chronological age alone.

It may consider:

  • Metabolic health.
  • Inflammation.
  • Organ function.
  • Blood markers.
  • Lifestyle factors.

Finding

Function Health reported:

Biological Age: Younger by approximately 13 years


Interpretation

This finding suggests that several measurable health factors are contributing positively to biological resilience.

Factors supporting this result include:

  • Low inflammatory markers.
  • Excellent glucose regulation.
  • Low insulin levels.
  • Strong kidney function.
  • Adequate nutrition.
  • Favorable lifestyle patterns.

2. Inflammation and Aging

Why Inflammation Matters

Chronic inflammation is one of the major contributors to accelerated aging.

It is associated with:

  • Cardiovascular disease.
  • Metabolic decline.
  • Tissue damage.
  • Reduced resilience.

Personal Trend

Marker20212026
CRP32Very low
ESR716

Interpretation

The reduction in inflammatory markers represents one of the strongest longevity indicators in the Health Inventory.

Current status:

✅ Low inflammatory burden
✅ No evidence of active systemic inflammation


3. Metabolic Longevity Markers

Key Markers

  • Hemoglobin A1c
  • Fasting glucose
  • Insulin
  • Leptin
  • Triglycerides

Findings

Current metabolic profile:

  • A1c: approximately 5.5%
  • Insulin: 2.1
  • Leptin: 0.4
  • Triglycerides: very low

Interpretation

These markers suggest:

  • Excellent insulin sensitivity.
  • Low metabolic stress.
  • Favorable energy regulation.

Metabolic health is one of the strongest predictors of healthy aging.


4. Cardiovascular Longevity Markers

Favorable Findings

Your cardiovascular profile includes:

✅ Very high HDL
✅ Low triglycerides
✅ Low inflammation
✅ Low Lipoprotein(a)
✅ Excellent glucose control


Areas for Continued Attention

Markers requiring monitoring:

  • LDL cholesterol.
  • ApoB.
  • LDL particle number.

Interpretation

The cardiovascular longevity picture is balanced:

Strong protective factors exist, while LDL-related risk requires continued individualized evaluation.


5. Hormonal Health and Aging

Testing Included

Function Health evaluated:

  • Testosterone.
  • Free testosterone.
  • SHBG.
  • DHEA.
  • LH.
  • FSH.
  • Estradiol.
  • Prolactin.

Interpretation

Hormonal markers provide a baseline for monitoring healthy aging.

The value of these measurements is not a single number but observing:

  • Stability over time.
  • Relationship to strength.
  • Energy.
  • Function.
  • Overall quality of life.

6. Thyroid and Aging

Thyroid function affects:

  • Energy.
  • Metabolism.
  • Temperature regulation.
  • Cardiovascular function.

Current pattern:

  • TSH normal.
  • Free T4 normal.
  • Free T3 lower.

Interpretation

Thyroid replacement remains effective.

The Free T3 pattern should continue to be monitored because thyroid function influences healthy aging.


7. Muscle and Functional Longevity

Although laboratory tests do not directly measure strength, several markers support healthy muscle function.

Supporting findings:

  • Adequate protein intake.
  • Normal kidney function.
  • Normal nutritional markers.
  • Normal blood counts.
  • Improved inflammatory status.

Interpretation

The combination of nutrition, low inflammation, and metabolic health supports maintaining physical function with aging.


8. Lifestyle Factors Supporting Longevity

The Health Inventory documents several lifestyle practices:

Nutrition

Since January 1, 2024:

  • Strict carnivore diet.
  • Focus on eating for health rather than pleasure.
  • High-quality protein intake.

Monitoring

Current plan:

Four laboratory evaluations annually:

  • March — WellMed
  • June — Function Health
  • September — WellMed
  • December — Function Health

Each followed by review with Dr. George.


Purpose

This creates a continuous feedback loop:

Lifestyle → Laboratory Data → Physician Review → Adjustment


Longevity Summary Table

CategoryCurrent Status
Biological ageFavorable
InflammationExcellent
Blood healthRecovered
Metabolic healthExcellent
NutritionExcellent
Kidney functionExcellent
ThyroidControlled, monitor Free T3
Cardiovascular healthStrong but LDL/ApoB monitored
Autoimmune markersPresent, monitor
Lifestyle monitoringExcellent


Overall Interpretation

The aging and longevity trends demonstrate a remarkable transition from illness recovery to health optimization.

The laboratory record shows:

  • Resolution of severe inflammation.
  • Recovery of blood health.
  • Excellent metabolic function.
  • Strong nutritional status.
  • Preserved organ function.
  • Advanced preventive monitoring.

The most accurate summary is:

Current health markers indicate strong biological resilience and multiple indicators associated with healthy aging. Continued monitoring should focus on cardiovascular risk refinement, autoimmune surveillance, and maintaining the lifestyle practices that have supported recovery and health.


Related Sections

This trend analysis connects directly with:

7.2.10 Physician Discussion Summary


Physician Discussion Summary

Purpose

The purpose of this section is to translate laboratory trends into practical discussion points for physician appointments.

This section provides:

  • Key health findings.
  • Important questions.
  • Areas requiring continued monitoring.
  • Topics for discussion with each physician.

The goal is not to replace physician judgment, but to ensure that appointments are focused, efficient, and based on a complete longitudinal health record.


Overview

The Health Inventory laboratory trends reveal a consistent story:

2021

A major systemic inflammatory illness occurred.

Findings:

  • Elevated ESR.
  • Elevated CRP.
  • Normocytic anemia.
  • Significant decline in health.

2022–2024

Recovery occurred.

Findings:

  • Inflammation resolved.
  • Blood counts improved.
  • Extensive evaluation excluded many possible causes.

2024–2026

Health optimization phase.

Findings:

  • Excellent metabolic health.
  • Very low inflammation.
  • Normal blood counts.
  • Strong nutritional markers.
  • Persistent autoimmune serology requiring monitoring.
  • Cardiovascular risk requiring individualized evaluation.

Current Health Summary for Physicians

Major Improvements

Inflammation

Current:

  • CRP very low.
  • ESR normal.

Interpretation:

No laboratory evidence of active systemic inflammation.


Blood Health

Current:

  • Hemoglobin normalized.
  • Iron/B12/folate adequate.

Interpretation:

Previous anemia has resolved.


Metabolic Health

Current:

  • Excellent glucose control.
  • Low insulin.
  • Favorable triglycerides.

Interpretation:

Strong metabolic health.


Kidney Function

Current:

  • Normal creatinine.
  • Preserved eGFR.
  • Normal urinalysis.

Interpretation:

Kidney function remains excellent.


Ongoing Areas for Monitoring

1. Autoimmune Serology

Findings:

  • ANA positive.
  • Homogeneous pattern.
  • ANA titer increased.
  • Disease-specific antibodies negative.
  • ESR/CRP normal.

Current question:

Is this persistent immune activity requiring monitoring only, or does it suggest future risk?


2. Cardiovascular Risk

Findings:

Positive:

  • High HDL.
  • Low triglycerides.
  • Low inflammation.
  • Excellent metabolic markers.

Areas of concern:

  • Elevated LDL.
  • Elevated ApoB.
  • Elevated LDL particle number.

Current question:

How should cardiovascular risk be interpreted using the complete profile rather than LDL alone?


3. Thyroid Function

Findings:

  • TSH normal.
  • Free T4 normal.
  • Free T3 lower.

Current question:

Does the Free T3 pattern require action or continued observation?


4. Diet and Long-Term Monitoring

Current diet:

  • Carnivore diet since January 1, 2024.

Positive outcomes:

  • Reduced inflammation.
  • Improved symptoms.
  • Excellent metabolic markers.

Current question:

What laboratory markers should continue to be monitored long term?


Physician Discussion Guide


Dr. George — Primary Care

Purpose of Visit

Maintain the overall health strategy and coordinate care.


Key Discussion Points
1. Four Annual Laboratory Schedule

Current plan:

  • March — WellMed laboratory testing.
  • June — Function Health.
  • September — WellMed laboratory testing.
  • December — Function Health.

Questions:

  1. Are these intervals appropriate?
  2. Are there additional routine tests that should be included?
  3. Which trends deserve the closest attention?

2. Overall Health Assessment

Discussion:

The Health Inventory demonstrates:

  • Resolved inflammation.
  • Recovered blood counts.
  • Excellent metabolic health.
  • Preserved organ function.

Question:

Are there additional preventive measures recommended given this current health status?


3. Autoimmune Monitoring

Questions:

  1. Should ANA and related markers be periodically repeated?
  2. What symptoms would warrant earlier evaluation?
  3. Should rheumatology follow-up remain part of long-term monitoring?

4. Nutrition and Supplements

Questions:

  1. Are current supplements appropriate?
  2. Should Vitamin D levels influence supplementation decisions?
  3. Are additional nutritional markers recommended?

Dr. Yoo — Cardiology

Purpose of Visit

Evaluate cardiovascular risk in the context of complete health history.


Key Discussion Points
1. Lipid Interpretation

Current pattern:

  • LDL elevated.
  • ApoB elevated.
  • LDL particle number elevated.

Protective factors:

  • HDL high.
  • Triglycerides low.
  • Inflammation low.
  • Glucose excellent.

Questions:

  1. How should overall cardiovascular risk be calculated with this pattern?
  2. What LDL/ApoB targets are appropriate?
  3. Is additional risk assessment useful?

Possible considerations:

  • Coronary artery calcium scoring.
  • Imaging.
  • Additional cardiovascular testing.

2. Blood Pressure Management

History:

  • Hypertension treated with Amlodipine.
  • Blood pressure became low enough to reduce medication.

Questions:

  1. What blood pressure range is ideal?
  2. Should medication remain discontinued?
  3. How frequently should home monitoring occur?

3. Cardiac History

History:

  • Atrial fibrillation.
  • Watchman implant.
  • Ascending aortic aneurysm.

Questions:

  1. Are current monitoring intervals appropriate?
  2. Are there additional preventive measures recommended?

Dr. Saifi — Rheumatology

Purpose of Visit

Interpret autoimmune findings in the context of resolved inflammation.


Key Discussion Points
1. ANA Interpretation

Current findings:

  • ANA 1:1280.
  • Homogeneous pattern.
  • Disease-specific antibodies negative.
  • ESR normal.
  • CRP very low.

Questions:

  1. How should this ANA pattern be interpreted?
  2. Does the titer require additional monitoring?
  3. Is this consistent with an inactive autoimmune process?

2. History of Inflammatory Illness

Questions:

  1. Could the 2021 illness represent a temporary autoimmune activation?
  2. Is recurrence risk increased?
  3. What symptoms should prompt reassessment?

Long-Term Monitoring Priorities

Continue Tracking

Inflammation
  • CRP.
  • ESR.
Autoimmune
  • ANA pattern and titer if clinically indicated.
  • Disease-specific antibodies if symptoms change.
Blood Health
  • CBC.
  • Hemoglobin trend.
Cardiovascular
  • Lipid panel.
  • ApoB.
  • LDL particle markers when appropriate.
Metabolic
  • Glucose.
  • A1c.
  • Insulin.
Kidney
  • Creatinine.
  • eGFR.
  • BUN.
Thyroid
  • TSH.
  • Free T4.
  • Free T3 when appropriate.
Nutrition
  • B12.
  • Folate.
  • Iron.
  • Vitamin D.
  • Minerals.

Physician Summary Statement

The Health Inventory laboratory record demonstrates:

A significant recovery from a severe inflammatory illness, with current evidence of excellent metabolic health, resolved anemia, preserved organ function, and controlled inflammation. The primary ongoing areas for monitoring are cardiovascular risk refinement, persistent autoimmune markers, and continued optimization of long-term health.


Final Assessment

Section 7.2 — Laboratory Trends & Analysis is now complete.

It transforms:

38 individual laboratory reports

into:

  • A health timeline.
  • A recovery story.
  • A physician discussion tool.
  • A framework for future monitoring.

Related Sections

This section connects with:

7.3 Longitudinal Trend Tables

Purpose

Provide the actual numerical tracking tables that allow changes over time to be seen quickly. There are seven trend tables:

Longitudinal Trend Tables

7.3.1 Inflammation Trend Table

Inflammation Trend Tables

Purpose

The purpose of this section is to document the changes in inflammatory markers over time and provide a clear visual representation of the transition from severe systemic inflammation in 2021 to the current state of inflammatory control.

The primary inflammatory markers reviewed are:

  • C-Reactive Protein (CRP)
  • Erythrocyte Sedimentation Rate (ESR)

These markers are especially important because inflammation was the defining health challenge during the 2021 period of severe illness.


Table 1 — C-Reactive Protein (CRP) Trend

DateLaboratoryCRP ResultInterpretation
October 2021Laboratory Testing32 mg/LSevere systemic inflammation
2022Follow-up TestingImprovedRecovery phase
June 2024Labcorp2 mg/LLow inflammatory activity
November 2024Labcorp1 mg/LExcellent inflammatory control
June 2026Function Health / QuestVery lowNo evidence of active inflammation

CRP Trend Summary

The CRP trend demonstrates one of the clearest improvements documented in the Health Inventory.

2021

CRP of 32 mg/L indicated a significant inflammatory response.

This occurred with:

  • Severe decline in health.
  • Elevated ESR.
  • Normocytic anemia.
  • Significant systemic symptoms.

2024–2026

CRP decreased to very low levels.

Current interpretation:

✓ Inflammatory activity greatly improved.
✓ No laboratory evidence of ongoing systemic inflammation.
✓ Continued monitoring appropriate because of autoimmune history.


Table 2 — Erythrocyte Sedimentation Rate (ESR) Trend

DateLaboratoryESR ResultInterpretation
October 2021Laboratory Testing71 mm/hrSevere inflammatory response
2022Follow-up TestingImprovedRecovery phase
September 2023Laboratory Testing27 mm/hrImproved inflammatory status
June 2026Function Health / Quest6 mm/hrExcellent inflammatory control

ESR Trend Summary

The ESR trend mirrors the CRP improvement.

The reduction from:

71 mm/hr → 6 mm/hr

represents a significant objective measure of recovery.

Current interpretation:

✓ No evidence of active systemic inflammation.
✓ Previous inflammatory illness appears resolved.
✓ Continued observation appropriate because autoimmune markers remain present.


Table 3 — Combined Inflammation Trend Summary

Time PeriodCRPESRHealth Status
20213271Severe inflammatory illness
2022ImprovingImprovingRecovery phase
2023Improved27Continued recovery
20241–2—Low inflammatory state
2026Very low6Excellent inflammatory control

Overall Inflammation Assessment

The laboratory trend demonstrates a clear progression:

Phase 1 — Active Inflammation (2021)

Findings:

  • CRP elevated.
  • ESR elevated.
  • Anemia present.
  • Significant decline in health.

Phase 2 — Recovery (2022–2023)

Findings:

  • Inflammatory markers decreased.
  • Blood counts began improving.
  • Extensive evaluation performed.

Phase 3 — Inflammatory Control (2024–2026)

Findings:

  • CRP remains very low.
  • ESR normal.
  • Blood counts recovered.
  • No evidence of active systemic inflammation.

Clinical Significance

The inflammation trend is one of the strongest indicators of recovery in the Health Inventory.

The overall conclusion is:

The severe systemic inflammatory state documented in 2021 has resolved, with current laboratory evidence demonstrating excellent inflammatory control. Persistent autoimmune markers remain an area for monitoring but are not accompanied by current evidence of active inflammation.


Related Sections

This trend table connects directly with:


Navigation

Previous Section: Section 7.3 — Longitudinal Trend Tables Index
Current Section: Section 7.3.1 — Inflammation Trend Tables
Next Section: Section 7.3.2 — Blood Health Trend Tables
Return to Section 7 — Laboratory Archive

7.3.2 Blood Health Trend Table

Blood Health Trend Tables

Purpose

The purpose of this section is to document blood-related laboratory changes over time and provide a clear visual representation of the progression from anemia during the inflammatory illness to complete hematologic recovery.

The primary blood health markers reviewed are:

  • Hemoglobin
  • Hematocrit
  • Red Blood Cell Count
  • Mean Corpuscular Volume (MCV)
  • Iron Status
  • Ferritin
  • Vitamin B12
  • Folate
  • White Blood Cell Count
  • Platelet Count

These markers help evaluate:

  • Oxygen-carrying capacity.
  • Red blood cell production.
  • Nutritional status.
  • Bone marrow function.
  • Recovery from systemic illness.

Table 1 — Hemoglobin Trend

DateLaboratoryHemoglobinInterpretation
October 2021Laboratory Testing~11–12 g/dLReduced during severe inflammatory illness
December 2022Follow-up Testing13.8 g/dLRecovery demonstrated
September 2023Laboratory Testing11.3 g/dLNormocytic anemia recurrence
June 2024Labcorp11.2 g/dLContinued mild anemia
November 2024Labcorp12.6 g/dLImprovement beginning
June 2026Function Health / Quest13.6 g/dLNormal hematologic status

Hemoglobin Trend Summary

The hemoglobin trend demonstrates a clear recovery pattern.

2021

During the severe inflammatory illness:

  • Hemoglobin declined.
  • Normocytic anemia developed.
  • Inflammation markers were significantly elevated.

2023–2024

A temporary recurrence of anemia occurred.

Extensive evaluation showed:

  • No evidence of iron deficiency.
  • No evidence of B12 deficiency.
  • No evidence of folate deficiency.
  • No evidence of kidney-related anemia.

2026

Hemoglobin returned to a normal range.

Current interpretation:

✓ Anemia resolved.
✓ Blood production recovered.
✓ Continued routine monitoring appropriate.


Table 2 — Red Blood Cell Indices Trend

DateMCV PatternInterpretation
2021NormocyticConsistent with inflammation-associated anemia
2023NormocyticAnemia evaluation continued
2024NormocyticNo evidence of nutritional deficiency pattern
2026NormalNormal red blood cell production

Red Blood Cell Trend Summary

The consistent finding throughout the anemia period was:

Normocytic anemia

Meaning:

  • Red blood cells were normal in size.
  • The pattern did not suggest classic iron deficiency.
  • The pattern was more consistent with inflammation or systemic illness.

Table 3 — Nutritional Causes of Anemia Evaluation

MarkerFindingInterpretation
IronNormalIron deficiency not identified
FerritinNormalAdequate iron storage
Iron SaturationNormalAdequate availability
Vitamin B12ExcellentB12 deficiency excluded
FolateAdequateFolate deficiency excluded

Nutritional Evaluation Summary

The laboratory record demonstrates that nutritional deficiency was not the cause of the anemia.

This was an important finding because it redirected evaluation toward:

  • Inflammatory causes.
  • Systemic illness effects.
  • Recovery processes.

Table 4 — White Blood Cell and Platelet Trends

DateWhite Blood CellsPlateletsInterpretation
2021PreservedPreservedNo evidence of broad marrow suppression
2023–2024Generally normalNormalIsolated anemia pattern
June 2026NormalNormalHealthy blood cell production

White Blood Cell and Platelet Summary

The blood count pattern was reassuring because:

  • White blood cells remained stable.
  • Platelets remained stable.
  • The abnormality was primarily limited to red blood cells.

This pattern argues against a generalized bone marrow disorder.


Table 5 — Complete Blood Health Trend Summary

Time PeriodHemoglobin StatusKey FindingsOverall Assessment
2021ReducedSevere inflammation, anemiaIllness-associated decline
2022ImprovedRecovery phaseBlood counts improved
2023Reduced againNormocytic anemiaExpanded evaluation
2024ImprovingNo nutritional cause identifiedRecovery underway
2026NormalHematologic recovery completeCurrent stability

Overall Blood Health Assessment

The laboratory trend demonstrates a complete recovery pattern.

Major Findings

Past Concern

  • Normocytic anemia during and after systemic inflammatory illness.

Evaluation

Testing excluded:

  • Iron deficiency.
  • Vitamin B12 deficiency.
  • Folate deficiency.
  • Kidney-related causes.

Current Status

  • Normal hemoglobin.
  • Normal blood counts.
  • No evidence of ongoing anemia.

Clinical Significance

The blood health trend represents one of the strongest recovery stories documented in the Health Inventory.

The overall conclusion is:

The normocytic anemia appears to have been associated with systemic inflammation and illness rather than nutritional deficiency or progressive blood disease. Current laboratory findings demonstrate complete hematologic recovery.


Related Sections

This trend table connects directly with:

  • Section 2 — Medical History Timeline
  • Section 3.7 — History of Systemic Inflammatory Illness
  • Section 7.2.1 — Inflammation Trends
  • Section 7.2.3 — Blood Health Trends
  • Section 7.3.1 — Inflammation Trend Tables
  • Section 7.3.7 — Nutritional Trend Tables
  • Section 8 — Physician Consultation Summaries

Navigation

Previous Section: Section 7.3.1 — Inflammation Trend Tables
Current Section: Section 7.3.2 — Blood Health Trend Tables
Next Section: Section 7.3.3 — Cardiovascular Trend Tables
Return to Section 7 — Laboratory Archive

7.3.3 Cardiovascular Trend Table

Cardiovascular Laboratory Trend Tables

Purpose

The purpose of this section is to document cardiovascular laboratory changes over time by organizing key markers into longitudinal tables.

These tables allow trends to be easily reviewed by:

  • Patient
  • Primary care physician
  • Cardiologist
  • Future healthcare providers

The focus is on:

  • Lipid patterns.
  • Advanced cardiovascular markers.
  • Inflammatory risk markers.
  • Metabolic factors affecting cardiovascular health.

Table 1 — Standard Lipid Trends

DateTotal CholesterolLDL-CHDL-CTriglyceridesNon-HDL
June 20242201367550145
November 20242431419452149
December 20252561518960167
June 20262841838285—

Trend Summary

Positive Findings

  • HDL has remained consistently high.
  • Triglycerides have remained low.
  • Lipid pattern reflects strong metabolic health.

Area for Monitoring

  • LDL cholesterol has increased and requires continued physician evaluation.

Table 2 — Advanced Cardiovascular Markers

DateApoBLDL Particle NumberLipoprotein(a)
June 2025———
November 2025———
June 20261392483Low

Trend Summary

Advanced testing identifies:

  • Increased atherogenic particle burden.
  • Favorable Lipoprotein(a) status.

These findings should be interpreted with:

  • Inflammation.
  • Metabolic health.
  • Cardiac history.

Table 3 — Cardiovascular Inflammation & Metabolic Support Markers

DateCRPESRGlucoseA1cInsulin
October 20213271———
June 20242————
November 20241————
June 2026—6665.52.1

Trend Summary

The cardiovascular environment has improved significantly:

  • Inflammation resolved.
  • Glucose regulation excellent.
  • Insulin sensitivity excellent.

Overall Cardiovascular Trend Summary

The laboratory trends demonstrate:

Strengths

✓ Very high HDL
✓ Low triglycerides
✓ Excellent glucose regulation
✓ Very low inflammatory markers
✓ Low Lipoprotein(a)

Areas Requiring Monitoring

✓ LDL cholesterol
✓ ApoB
✓ LDL particle number
✓ Blood pressure history
✓ Cardiac history


Current Cardiovascular Assessment

The overall cardiovascular laboratory pattern is:

A metabolically favorable profile with excellent inflammatory control and strong metabolic markers, combined with elevated LDL-related particle measures requiring individualized cardiology assessment.


Related Sections

  • Section 3.1 — Hypertension
  • Section 3.2 — Hyperlipidemia
  • Section 3.3 — History of Atrial Fibrillation
  • Section 3.4 — Ascending Aortic Aneurysm
  • Section 7.2.4 — Cardiovascular Trends
  • Section 8 — Physician Consultation Summaries

Navigation

Previous Section: Section 7.3.1 — Inflammation Trend Tables
Current Section: Section 7.3.2 — Blood Health Trend Tables
Next Section: Section 7.3.3 — Cardiovascular Trend Tables
Return to Section 7 — Laboratory Archive

7.3.4 Metabolic Trend Table

Metabolic Trend Tables

Purpose

The purpose of this section is to document metabolic laboratory changes over time and provide a clear visual representation of glucose regulation, insulin sensitivity, and metabolic health.

The primary metabolic markers reviewed are:

  • Fasting Glucose
  • Hemoglobin A1c
  • Fasting Insulin
  • Leptin
  • Ketone Levels
  • Glucose Ketone Index (GKI)

These markers help evaluate:

  • Blood sugar control.
  • Insulin sensitivity.
  • Metabolic flexibility.
  • Risk of metabolic dysfunction.

Table 1 — Fasting Glucose Trend

DateLaboratoryGlucose ResultInterpretation
Earlier Laboratory TestingVariousNormal rangeStable glucose regulation
November 2024Labcorp87 mg/dLNormal glucose control
November 2025Function Health / Quest93 mg/dLNormal glucose control
June 2026Function Health / Quest66 mg/dLLow-normal glucose with excellent insulin sensitivity

Glucose Trend Summary

The glucose trend demonstrates stable and favorable blood sugar regulation.

Current interpretation:

✓ No evidence of diabetes.
✓ No evidence of impaired glucose regulation.
✓ Low glucose values occur in the context of excellent metabolic markers.

The June 2026 glucose value should be interpreted together with:

  • Low insulin.
  • Low leptin.
  • Normal A1c.
  • Dietary pattern.

Table 2 — Hemoglobin A1c Trend

DateLaboratoryA1c ResultInterpretation
January 2022Laboratory Testing5.6%Normal
December 2022Laboratory Testing5.7%Borderline elevation
June 2023Laboratory Testing5.6%Normal
September 2023Laboratory Testing5.8%Mild elevation
August 2024Labcorp5.4%Improved
November 2024Labcorp5.8%Mild variation
June 2026Function Health / Quest5.5%Normal

A1c Trend Summary

The A1c trend demonstrates long-term stability with improvement following lifestyle changes.

Major observations:

  • No progression toward diabetes.
  • Values remained near normal.
  • Recent results show favorable glucose control.

Table 3 — Insulin Trend

DateLaboratoryInsulin ResultInterpretation
November 2025Function Health / Quest4.6Favorable insulin sensitivity
June 2026Function Health / Quest2.1Excellent insulin sensitivity

Insulin Trend Summary

Insulin is one of the strongest indicators of metabolic health.

The reduction from:

4.6 → 2.1

suggests:

✓ Improved insulin efficiency.
✓ Reduced metabolic stress.
✓ Strong glucose utilization.


Table 4 — Leptin Trend

DateLaboratoryLeptin ResultInterpretation
November 2025Function Health / Quest1.1Favorable metabolic marker
June 2026Function Health / Quest0.4Very favorable metabolic marker

Leptin Trend Summary

Low leptin levels are consistent with:

  • Improved insulin sensitivity.
  • Lower metabolic inflammation.
  • Favorable energy regulation.

The June 2026 value supports the broader pattern of excellent metabolic health.


Table 5 — Ketone and GKI Tracking

Personal Metabolic Measurement

DateGlucoseKetonesGKIInterpretation
January 4, 202678 mg/dL4.7 mmol/L0.9Strong ketogenic state

Ketone/GKI Summary

The GKI measurement demonstrates the body’s ability to effectively use fat-derived fuel.

This indicates:

  • Strong metabolic flexibility.
  • Efficient ketone production.
  • Adaptation to low-carbohydrate nutrition.

Table 6 — Metabolic Health Summary

Time PeriodMajor FindingsOverall Assessment
2021–2023Stable glucose with some A1c variationMonitoring phase
2024Lifestyle transition beginsMetabolic improvement
2025Advanced metabolic assessment addedStrong metabolic profile
2026Low insulin, low leptin, normal A1cExcellent metabolic health

Overall Metabolic Assessment

The laboratory trends demonstrate a strong pattern of metabolic health.

Major Strengths

✓ Normal glucose regulation
✓ Normal A1c
✓ Very low insulin
✓ Very low leptin
✓ Favorable triglycerides
✓ Strong ketogenic flexibility


Relationship to Lifestyle Changes

Beginning:

January 1, 2024

Lifestyle approach:

  • Strict carnivore diet.
  • Focus on health optimization.
  • Consistent monitoring.

Associated laboratory trends:

  • Improved inflammation.
  • Improved metabolic markers.
  • Excellent insulin sensitivity.
  • Continued low triglycerides.

Clinical Significance

Metabolic health is one of the strongest positive themes in the Health Inventory.

The overall conclusion is:

The metabolic laboratory trend demonstrates excellent glucose regulation, strong insulin sensitivity, and favorable metabolic flexibility. Current findings support a state of low metabolic risk with continued monitoring appropriate as part of long-term health management.


Physician Discussion Points

Questions for Dr. George

  1. Should fasting insulin and metabolic markers continue to be monitored with the quarterly laboratory schedule?
  2. How should low glucose values be interpreted given excellent metabolic health and dietary patterns?
  3. Are additional metabolic markers recommended for long-term monitoring?

Questions for Dr. Yoo

  1. How should excellent metabolic markers influence cardiovascular risk interpretation?
  2. Does improved insulin sensitivity modify overall cardiovascular assessment?

Related Sections

This trend table connects directly with:

  • Section 6 — Lifestyle & Health Goals
  • Section 7.2.5 — Metabolic Trends
  • Section 7.3.3 — Cardiovascular Trend Tables
  • Section 7.3.5 — Kidney Function Trend Tables
  • Section 9 — Current Supplements & Diet Notes

Navigation

Previous Section: Section 7.3.3 — Cardiovascular Trend Tables
Current Section: Section 7.3.4 — Metabolic Trend Tables
Next Section: Section 7.3.5 — Kidney Function Trend Tables
Return to Section 7 — Laboratory Archive

7.3.5 Kidney Trend Table

Kidney Function Trend Tables

Purpose

The purpose of this section is to document kidney-related laboratory changes over time and provide a clear visual representation of kidney filtration, hydration-related markers, and evidence of kidney health.

The primary kidney markers reviewed are:

  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Blood Urea Nitrogen (BUN)
  • BUN/Creatinine Ratio
  • Urinalysis Findings

These markers help evaluate:

  • Kidney filtration ability.
  • Kidney injury risk.
  • Protein metabolism.
  • Long-term kidney health.

Table 1 — Creatinine Trend

DateLaboratoryCreatinine ResultInterpretation
June 2024Labcorp0.92 mg/dLNormal kidney filtration marker
November 2024Labcorp0.88 mg/dLNormal kidney filtration marker
November 2025Function Health / QuestNormalStable kidney function
June 2026Function Health / QuestNormalPreserved kidney function

Creatinine Trend Summary

Creatinine has remained stable throughout the laboratory record.

Current interpretation:

✓ No evidence of declining kidney filtration.
✓ No evidence of progressive kidney disease.
✓ Stable kidney function despite dietary changes.


Table 2 — Estimated Glomerular Filtration Rate (eGFR) Trend

DateLaboratoryeGFR ResultInterpretation
June 2024Labcorp81 mL/min/1.73m²Normal kidney function
November 2024Labcorp83 mL/min/1.73m²Stable kidney function
November 2025Function Health / QuestPreservedStable filtration
June 2026Function Health / QuestPreservedStable filtration

eGFR Trend Summary

The eGFR trend demonstrates preserved kidney filtration.

Important observations:

  • No progressive decline.
  • No evidence of chronic kidney disease.
  • Kidney function remains appropriate for long-term monitoring.

Table 3 — Blood Urea Nitrogen (BUN) Trend

DateLaboratoryBUN ResultInterpretation
June 2024Labcorp40 mg/dLElevated; interpret with diet and hydration
November 2024Labcorp33 mg/dLElevated; stable pattern
November 2025Function Health / QuestMonitoredContinued observation
June 2026Function Health / QuestMonitoredContinued observation

BUN Trend Summary

BUN has been the primary kidney-related marker requiring interpretation.

An elevated BUN may occur with:

  • Higher protein intake.
  • Fasting.
  • Lower fluid intake.
  • Increased protein metabolism.

In your case, elevated BUN occurs with:

  • Normal creatinine.
  • Preserved eGFR.
  • Normal urinalysis.

This pattern is more consistent with increased protein metabolism rather than impaired kidney function.


Table 4 — BUN/Creatinine Ratio Trend

DateLaboratoryRatioInterpretation
June 2024LabcorpElevatedConsistent with increased protein metabolism
November 2024LabcorpElevatedMonitor in dietary context
2025–2026Function Health / QuestMonitoredContinue observation

BUN/Creatinine Ratio Summary

The elevated ratio should not be interpreted independently.

The complete kidney picture demonstrates:

✓ Normal creatinine.
✓ Preserved eGFR.
✓ No urine abnormalities.

The most likely contributors are:

  • High dietary protein intake.
  • Carnivore diet.
  • Fasting practices.
  • Hydration variation.

Table 5 — Urinalysis Trend

DateLaboratoryFindingsInterpretation
2024LabcorpNormalNo evidence of kidney injury
2025Function Health / QuestNormalContinued kidney stability
2026Function Health / QuestNormalNo evidence of kidney damage

Urinalysis Trend Summary

Urinalysis provides important confirmation of kidney health.

Findings:

✓ No significant protein leakage.
✓ No blood detected.
✓ No evidence of urinary infection.
✓ No evidence of kidney injury.


Table 6 — Kidney Function Summary

Time PeriodMajor FindingsOverall Assessment
2021–2023Kidney function remained stable during illness and recoveryPreserved kidney function
2024Elevated BUN identified with normal filtration markersMonitor dietary influence
2025Advanced testing confirmed stabilityNo kidney disease evidence
2026Normal filtration and urinalysisExcellent kidney health

Overall Kidney Assessment

The laboratory trends demonstrate strong kidney health.

Major Strengths

✓ Normal creatinine
✓ Preserved eGFR
✓ Normal urinalysis
✓ No evidence of kidney damage
✓ Stable function over time


Relationship to Lifestyle Changes

Beginning:

January 1, 2024

Dietary approach:

  • Beef.
  • Eggs.
  • Butter.
  • Salt.
  • Raw whole milk.

The laboratory response demonstrates:

Positive findings:

  • Stable kidney filtration.
  • Normal creatinine.
  • Normal urine testing.

Finding requiring monitoring:

  • Elevated BUN.

Clinical Significance

The kidney trend provides important reassurance because kidney function is often a concern with significant dietary changes.

The overall conclusion is:

Kidney function remains excellent, with preserved filtration and no evidence of kidney disease. Elevated BUN values should continue to be monitored but interpreted within the context of increased protein intake, fasting practices, and hydration status.


Physician Discussion Points

Questions for Dr. George

  1. Is the current kidney monitoring schedule appropriate with four annual laboratory evaluations?
  2. Should hydration status be standardized before laboratory testing?
  3. Are additional kidney markers recommended for long-term monitoring?

Questions for Dr. Yoo

  1. Does preserved kidney function influence cardiovascular risk assessment?
  2. Should kidney markers continue to be incorporated into cardiovascular monitoring?

Related Sections

This trend table connects directly with:

  • Section 6 — Lifestyle & Health Goals
  • Section 7.2.6 — Kidney Function Trends
  • Section 7.3.4 — Metabolic Trend Tables
  • Section 7.3.7 — Nutritional Trend Tables
  • Section 9 — Current Supplements & Diet Notes

Navigation

Previous Section: Section 7.3.4 — Metabolic Trend Tables
Current Section: Section 7.3.5 — Kidney Function Trend Tables
Next Section: Section 7.3.6 — Thyroid Trend Tables
Return to Section 7 — Laboratory Archive

7.3.6 Thyroid Trend Table

Thyroid Function Trend Tables

Purpose

The purpose of this section is to document thyroid-related laboratory changes over time and provide a clear visual representation of thyroid replacement effectiveness and hormone balance.

The primary thyroid markers reviewed are:

  • Thyroid-Stimulating Hormone (TSH)
  • Free Thyroxine (Free T4)
  • Free Triiodothyronine (Free T3)
  • Thyroid Antibodies

These markers help evaluate:

  • Effectiveness of thyroid replacement therapy.
  • Thyroid hormone availability.
  • Thyroid stability.
  • Possible autoimmune thyroid activity.

Thyroid History

Condition

Hypothyroidism

Current Treatment

Levothyroxine — 75 mcg daily

The purpose of replacement therapy is to maintain adequate thyroid hormone availability and prevent symptoms associated with low thyroid function.


Table 1 — Thyroid-Stimulating Hormone (TSH) Trend

DateLaboratoryTSH ResultInterpretation
June 2024Labcorp0.819 μIU/mLNormal thyroid control
November 2024Labcorp1.110 μIU/mLStable thyroid replacement
November 2025Function Health / QuestNormalContinued control
June 2026Function Health / QuestNormalStable thyroid function

TSH Trend Summary

TSH has remained consistently controlled while taking levothyroxine.

Current interpretation:

✓ Thyroid replacement appears effective.
✓ No evidence of under-treatment.
✓ No evidence of significant over-treatment.


Table 2 — Free T4 Trend

DateLaboratoryFree T4 ResultInterpretation
June 2024Labcorp1.31 ng/dLNormal thyroid hormone availability
November 2024Labcorp1.24 ng/dLStable replacement level
November 2025Function Health / QuestNormalStable
June 2026Function Health / QuestNormalStable

Free T4 Trend Summary

Free T4 levels have remained within a healthy range.

This supports:

✓ Adequate thyroid hormone replacement.
✓ Stable circulating thyroxine availability.
✓ Consistent thyroid management.


Table 3 — Free T3 Trend

DateLaboratoryFree T3 ResultInterpretation
November 2025Function Health / QuestBelow reference rangeLower active thyroid hormone level identified
June 2026Function Health / QuestBelow reference rangePersistent lower Free T3 pattern

Free T3 Trend Summary

Free T3 represents the active thyroid hormone available to tissues.

The persistent finding is:

  • Lower Free T3.
  • Normal TSH.
  • Normal Free T4.

This creates a pattern requiring interpretation rather than immediate assumption of thyroid failure.

Possible contributing factors include:

  • Individual thyroid hormone conversion differences.
  • Aging-related changes.
  • Low-carbohydrate nutritional patterns.
  • Fasting or metabolic adaptation.

Table 4 — Thyroid Antibody Trend

DateLaboratoryFindingInterpretation
2025Function Health / QuestThyroid antibodies negativeNo evidence of autoimmune thyroid disease
2026Function Health / QuestThyroid antibodies negativeContinued absence of thyroid autoimmune markers

Thyroid Antibody Summary

The absence of thyroid antibodies is an important finding because of the broader autoimmune history.

Current interpretation:

✓ Hypothyroidism is controlled.
✓ No laboratory evidence of autoimmune thyroid destruction.


Table 5 — Complete Thyroid Trend Summary

Time PeriodMajor FindingsOverall Assessment
Earlier yearsHypothyroidism managed with medicationStable condition
2024Normal TSH and Free T4Effective replacement
2025Lower Free T3 identifiedAdditional monitoring needed
2026Persistent Free T3 pattern with normal TSH/Free T4Stable thyroid control

Overall Thyroid Assessment

The thyroid trend demonstrates effective management of hypothyroidism.

Major Strengths

✓ Normal TSH
✓ Normal Free T4
✓ Stable levothyroxine therapy
✓ Negative thyroid antibodies


Area for Continued Monitoring

Lower Free T3 Pattern

The current question is not whether thyroid replacement is working—it is:

How should a lower Free T3 level be interpreted when TSH and Free T4 remain normal?

This should be considered alongside:

  • Symptoms.
  • Energy level.
  • Metabolic health.
  • Weight stability.
  • Cardiovascular history.

Relationship to Other Health Trends

Thyroid and Cardiovascular Health

Thyroid hormone levels influence:

  • Heart rhythm.
  • Cholesterol metabolism.
  • Cardiovascular function.

Because of your history of:

  • Atrial fibrillation.
  • Hypertension.
  • Lipid monitoring.

continued thyroid monitoring remains appropriate.


Thyroid and Metabolic Health

The thyroid trend should also be interpreted alongside:

✓ Normal A1c
✓ Very low insulin
✓ Favorable triglycerides
✓ Excellent metabolic markers

The overall metabolic picture remains strong.


Clinical Significance

The thyroid trend demonstrates a stable and well-managed condition.

The overall conclusion is:

Thyroid replacement therapy is providing excellent control of standard thyroid markers. The persistent lower Free T3 pattern should continue to be monitored and interpreted within the context of symptoms, metabolic health, and overall clinical status.


Physician Discussion Points

Questions for Dr. George

  1. Should Free T3 continue to be monitored along with TSH and Free T4?
  2. Does the lower Free T3 value require intervention or continued observation?
  3. Could dietary pattern, fasting, or metabolic adaptation influence Free T3 levels?

Questions for Dr. Yoo

  1. Is the current thyroid replacement level appropriate given the history of atrial fibrillation?
  2. Should thyroid levels be considered when evaluating cardiovascular risk?

Related Sections

This trend table connects directly with:

  • Section 3.5 — Hypothyroidism
  • Section 3.6 — Autoimmune Serology
  • Section 7.2.7 — Thyroid Trends
  • Section 7.3.3 — Cardiovascular Trend Tables
  • Section 7.3.4 — Metabolic Trend Tables

Navigation

Previous Section: Section 7.3.5 — Kidney Function Trend Tables
Current Section: Section 7.3.6 — Thyroid Function Trend Tables
Next Section: Section 7.3.7 — Nutritional Trend Tables
Return to Section 7 — Laboratory Archive

7.3.7 Nutritional Trend Table

Thyroid Function Trend Tables

Purpose

The purpose of this section is to document thyroid-related laboratory changes over time and provide a clear visual representation of thyroid replacement effectiveness and hormone balance.

The primary thyroid markers reviewed are:

  • Thyroid-Stimulating Hormone (TSH)
  • Free Thyroxine (Free T4)
  • Free Triiodothyronine (Free T3)
  • Thyroid Antibodies

These markers help evaluate:

  • Effectiveness of thyroid replacement therapy.
  • Thyroid hormone availability.
  • Thyroid stability.
  • Possible autoimmune thyroid activity.

Thyroid History

Condition

Hypothyroidism

Current Treatment

Levothyroxine — 75 mcg daily

The purpose of replacement therapy is to maintain adequate thyroid hormone availability and prevent symptoms associated with low thyroid function.


Table 1 — Thyroid-Stimulating Hormone (TSH) Trend

DateLaboratoryTSH ResultInterpretation
June 2024Labcorp0.819 μIU/mLNormal thyroid control
November 2024Labcorp1.110 μIU/mLStable thyroid replacement
November 2025Function Health / QuestNormalContinued control
June 2026Function Health / QuestNormalStable thyroid function

TSH Trend Summary

TSH has remained consistently controlled while taking levothyroxine.

Current interpretation:

✓ Thyroid replacement appears effective.
✓ No evidence of under-treatment.
✓ No evidence of significant over-treatment.


Table 2 — Free T4 Trend

DateLaboratoryFree T4 ResultInterpretation
June 2024Labcorp1.31 ng/dLNormal thyroid hormone availability
November 2024Labcorp1.24 ng/dLStable replacement level
November 2025Function Health / QuestNormalStable
June 2026Function Health / QuestNormalStable

Free T4 Trend Summary

Free T4 levels have remained within a healthy range.

This supports:

✓ Adequate thyroid hormone replacement.
✓ Stable circulating thyroxine availability.
✓ Consistent thyroid management.


Table 3 — Free T3 Trend

DateLaboratoryFree T3 ResultInterpretation
November 2025Function Health / QuestBelow reference rangeLower active thyroid hormone level identified
June 2026Function Health / QuestBelow reference rangePersistent lower Free T3 pattern

Free T3 Trend Summary

Free T3 represents the active thyroid hormone available to tissues.

The persistent finding is:

  • Lower Free T3.
  • Normal TSH.
  • Normal Free T4.

This creates a pattern requiring interpretation rather than immediate assumption of thyroid failure.

Possible contributing factors include:

  • Individual thyroid hormone conversion differences.
  • Aging-related changes.
  • Low-carbohydrate nutritional patterns.
  • Fasting or metabolic adaptation.

Table 4 — Thyroid Antibody Trend

DateLaboratoryFindingInterpretation
2025Function Health / QuestThyroid antibodies negativeNo evidence of autoimmune thyroid disease
2026Function Health / QuestThyroid antibodies negativeContinued absence of thyroid autoimmune markers

Thyroid Antibody Summary

The absence of thyroid antibodies is an important finding because of the broader autoimmune history.

Current interpretation:

✓ Hypothyroidism is controlled.
✓ No laboratory evidence of autoimmune thyroid destruction.


Table 5 — Complete Thyroid Trend Summary

Time PeriodMajor FindingsOverall Assessment
Earlier yearsHypothyroidism managed with medicationStable condition
2024Normal TSH and Free T4Effective replacement
2025Lower Free T3 identifiedAdditional monitoring needed
2026Persistent Free T3 pattern with normal TSH/Free T4Stable thyroid control

Overall Thyroid Assessment

The thyroid trend demonstrates effective management of hypothyroidism.

Major Strengths

✓ Normal TSH
✓ Normal Free T4
✓ Stable levothyroxine therapy
✓ Negative thyroid antibodies


Area for Continued Monitoring

Lower Free T3 Pattern

The current question is not whether thyroid replacement is working—it is:

How should a lower Free T3 level be interpreted when TSH and Free T4 remain normal?

This should be considered alongside:

  • Symptoms.
  • Energy level.
  • Metabolic health.
  • Weight stability.
  • Cardiovascular history.

Relationship to Other Health Trends

Thyroid and Cardiovascular Health

Thyroid hormone levels influence:

  • Heart rhythm.
  • Cholesterol metabolism.
  • Cardiovascular function.

Because of your history of:

  • Atrial fibrillation.
  • Hypertension.
  • Lipid monitoring.

continued thyroid monitoring remains appropriate.


Thyroid and Metabolic Health

The thyroid trend should also be interpreted alongside:

✓ Normal A1c
✓ Very low insulin
✓ Favorable triglycerides
✓ Excellent metabolic markers

The overall metabolic picture remains strong.


Clinical Significance

The thyroid trend demonstrates a stable and well-managed condition.

The overall conclusion is:

Thyroid replacement therapy is providing excellent control of standard thyroid markers. The persistent lower Free T3 pattern should continue to be monitored and interpreted within the context of symptoms, metabolic health, and overall clinical status.


Physician Discussion Points

Questions for Dr. George

  1. Should Free T3 continue to be monitored along with TSH and Free T4?
  2. Does the lower Free T3 value require intervention or continued observation?
  3. Could dietary pattern, fasting, or metabolic adaptation influence Free T3 levels?

Questions for Dr. Yoo

  1. Is the current thyroid replacement level appropriate given the history of atrial fibrillation?
  2. Should thyroid levels be considered when evaluating cardiovascular risk?

Related Sections

This trend table connects directly with:

  • Section 3.5 — Hypothyroidism
  • Section 3.6 — Autoimmune Serology
  • Section 7.2.7 — Thyroid Trends
  • Section 7.3.3 — Cardiovascular Trend Tables
  • Section 7.3.4 — Metabolic Trend Tables

Navigation

Previous Section: Section 7.3.5 — Kidney Function Trend Tables
Current Section: Section 7.3.6 — Thyroid Function Trend Tables
Next Section: Section 7.3.7 — Nutritional Trend Tables
Return to Section 7 — Laboratory Archive

Question answered

How have specific laboratory values changed year by year?


7.4 Laboratory Timeline

Purpose

The Laboratory Timeline identifies major turning points and explains how laboratory findings relate to the overall health journey.

Major Laboratory Milestones

2015 — Baseline Health Assessment

Established baseline values before the major inflammatory illness.

Key areas:

  • Normal kidney function
  • Normal liver function
  • Stable blood counts
  • Early lipid pattern documented

2021 — Peak Inflammatory Period

Major changes documented:

  • ESR elevated to 71
  • CRP elevated to 32
  • Normocytic anemia developed
  • Significant decline in health

2022 — Recovery Period

Findings:

  • Inflammatory markers improved
  • Physical health improved
  • Continued monitoring

2024 — Lifestyle Transformation

Major event:

  • Began strict carnivore diet January 1, 2024

Followed by:

  • Improved symptoms
  • Stable metabolic markers
  • Continued health improvement

2025–2026 — Comprehensive Evaluation

Major findings:

  • Persistent lipid pattern
  • Positive ANA
  • Antiphospholipid antibody findings
  • Normal inflammatory markers

7.5 Laboratory Interpretation

Purpose

This section explains what laboratory trends mean clinically.

It focuses on patterns rather than individual values.

Examples:

Cardiovascular Interpretation

Questions addressed:

  • How should LDL and ApoB be interpreted?
  • How does high HDL and low triglycerides affect risk?
  • How do inflammation markers influence cardiovascular assessment?

Autoimmune Interpretation

Questions addressed:

  • What does persistent ANA positivity mean?
  • How should autoimmune antibodies be interpreted when CRP and ESR are normal?

Hematology Interpretation

Questions addressed:

  • Why did anemia appear during illness?
  • Why did blood counts later improve?

Metabolic Interpretation

Questions addressed:

  • How has diet affected glucose regulation?
  • What do fasting glucose, ketones, and GKI demonstrate?

7.6 Laboratory Reports

Purpose

This section contains detailed one-page summaries of individual laboratory reports.

Each report includes:

  • Date
  • Laboratory
  • Purpose of testing
  • Major findings
  • Clinical interpretation
  • Longitudinal significance
  • Related health sections

Example:

2015 Labcorp Report

A baseline health assessment documenting:

  • Kidney function
  • Liver function
  • Blood counts
  • Lipid profile
  • Glucose regulation
  • Thyroid function

7.7 Physician Reports

Purpose

This section organizes laboratory information according to physician needs.

Dr. Yoo — Cardiology

Focus areas:

  • Blood pressure
  • Lipids
  • ApoB
  • Cardiovascular risk
  • BNP
  • Inflammation

Dr. Saifi — Rheumatology

Focus areas:

  • ANA
  • Autoimmune markers
  • ESR
  • CRP
  • Inflammatory illness history

Dr. George — Primary Care

Focus areas:

  • Overall health
  • Preventive care
  • Medication review
  • Annual assessment

7.8 Annual Laboratory Reviews

Purpose

This section provides a yearly summary of health changes.

Each annual review includes:

  • Major improvements
  • New findings
  • Laboratory trends
  • Physician recommendations
  • Future monitoring goals

7.9 Laboratory Glossary

Purpose

This section explains laboratory markers in understandable language.

Examples:

  • ANA
  • CRP
  • ESR
  • ApoB
  • LDL
  • HDL
  • eGFR
  • HbA1c

Each entry includes:

  • What the test measures
  • Why it is important
  • Personal history
  • Related reports

7.10 Laboratory Insights

Purpose

This section summarizes the major lessons learned from years of laboratory data.

Examples:

Inflammation

The severe inflammatory illness of 2021 resolved, with normalization of CRP and ESR.


Lipids

A stable pattern exists of:

  • Elevated LDL
  • High HDL
  • Low triglycerides

Autoimmune Findings

Strong immune markers exist without current evidence of active systemic inflammation.


Kidney Function

Kidney function has remained stable over time.


Overall Laboratory Perspective

Long-term trends provide a clearer understanding of health than isolated laboratory values.

7.11 Laboratory Milestones

Purpose

This section provides a quick-reference summary of the most important laboratory events.

Examples:

DateMilestoneSignificance
May 2015Baseline laboratory assessmentEstablished pre-inflammatory health baseline
October 2021Peak inflammationESR 71, CRP 32, anemia
2022Recovery phaseInflammation normalized
January 2024Carnivore diet beginsMajor lifestyle transition
2025Advanced cardiovascular testingLipid pattern confirmed
2026Function Health evaluationAutoimmune serology identified

Navigation